House Publications

The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Bilingual view PDF


Thursday, June 13, 2024 (No. 331)

Questions

Those questions not appearing in the list have been answered, withdrawn or made into orders for return.

Q-2599² — April 29, 2024 — — With regard to the Age Well at Home initiative: (a) how many organizations submitted projects between June 8, 2022, and July 29, 2022, in the constituency of Thérèse-De Blainville and, of these project submissions, how many (i) were approved, (ii) were denied, (iii) have not yet received a response; and (b) of the project applications in the constituency of Thérèse-De Blainville that have not yet received a response, (i) what are the estimated timelines for processing these applications, (ii) what are the reasons for these processing delays, (iii) will the amounts approved initially for these applications be adjusted for inflation?

Q-2600² — April 29, 2024 — — With regard to asylum claims made by individuals who arrived in Canada on a student visa, since 2018: how many claims (i) were accepted, (ii) were rejected, (iii) are still being processed, in total and broken down by the school in which the claimant was enrolled when the asylum claim was made?

Q-2601² — April 29, 2024 — — With regard to stakeholders that were consulted by the Deputy Prime Minister and Minister of Finance about what to include in budget 2024: (a) what were the names and titles of all stakeholders consulted; and (b) what are the details, including the date, location, and manner in which each of the stakeholders in (a) were consulted?

Q-2602² — April 29, 2024 — — With regard to the Canada Revenue Agency's (CRA) response to the Privacy Commissioner of Canada's special report to Parliament on February 15, 2024, indicating that a major privacy breach at the CRA involved "vast amounts of sensitive personal information" and that the CRA needed stronger security safeguards: (a) does the CRA accept the conclusions of the Privacy Commissioner that the current process and procedures that govern the handling of sensitive personal information are inadequate; (b) what steps is the CRA undertaking to rectify this lack of safeguards and due diligence to give Canadians confidence that their personal, sensitive and private information is secure with the CRA; (c) what steps is the CRA taking to limit collection until it can be confident that information can be properly secured; and (d) does the CRA take the position that seeking sensitive information from businesses with no sales or confirmed tax obligations would be a misuse of the Universal Periodic Review provisions, and, if not, why not?

Q-2603² — April 29, 2024 — — With regard to usage of the government's fleet of Challenger aircraft, since October 27, 2023: what are the details of the legs of each flight, including the (i) date, (ii) point of departure, (iii) destination, (iv) number of passengers, (v) names and titles of the passengers, excluding security or Canadian Armed Forces members, (vi) total catering bill related to the flight, (vii) volume of fuel used, or an estimate, (viii) amount spent on fuel?

Q-2604² — April 29, 2024 — — With regard to usage of the government's fleet of Airbus and Polaris aircraft since September 1, 2023: what are the details of the legs of each flight, including the (i) date, (ii) point of departure, (iii) destination, (iv) number of passengers, (v) names and titles of the passengers, excluding security or Canadian Armed Forces members, (vi) total catering bill related to the flight, (vii) volume of fuel used, or an estimate, (viii) amount spent on fuel, (ix) type of aircraft?

Q-2605² — April 29, 2024 — — With regard to the 140 conflict of interest declarations filed in the 2022-23 fiscal year, and the 162 conflict of interest declarations filed in the 2023-24 fiscal year concerning public servants employed in the core public administration who were involved in contractual relationships with the Government of Canada, broken down by fiscal year: (a) what is the breakdown of the declarations by department, agency or other government entity by which the public servant was employed; (b) what are the names of the vendors which have contracts with the government that were the subjects of the declarations; and (c) what are the details of each contract provided to the vendors in (b), including, for each, the (i) department, agency, or other government entity that signed the contract, (ii) vendor, (iii) date, (iv) amount, (v) description of goods or services, (vi) manner in which the contract was awarded (sole-sourced, competitive bid)?

Q-2606² — April 29, 2024 — — With regard to human resource complaints submitted by employees of Innovation, Science and Economic Development Canada, since January 1, 2016, broken down by year: (a) what was the total number of complaints broken down by the (i) name of the agency or Crown corporation employing the complainant, (ii) reason for the complaint, (iii) type of resolution or follow-up action that occurred; and (b) what was the average time between a complaint being filed and the matter being settled or otherwise concluded?

Q-2607² — April 29, 2024 — — With regard to tax owed to the government for unpaid excise tax on cannabis: (a) what is the current amount owed, in total and broken down by the province or territory of the entity owing tax; (b) how many separate taxpaying entities have unpaid excise tax on cannabis; and (c) what is the breakdown of (a) and (b) by the tax year from which the unpaid tax is owed?

Q-2608² — April 29, 2024 — — With regard to lethal and non-lethal military export control permits currently awaiting a governor-in-council decision: what are details of each item, including the (i) vendor, (ii) item description, (iii) dollar value of the export, (iv) date on which the control permit was referred to the governor-in-council for a decision, (v) country for which the item is destined?

Q-2609² — April 29, 2024 — — With regard to digital marketing firms contracted by the government to conduct digital marketing since 2016: what are the details of all contracts, including the (i) name of the firm contracted, (ii) commission provided to the marketing firm as part of the contract, (iii) total sum provided for marketing purposes, (iv) total amount used for marketing purposes, (v) marketing platforms used to communicate as part of the contract, (vi) policy initiative being communicated?

Q-2610² — April 29, 2024 — — With regard to the Canada Dental Benefit, to date: how many Canadians have (i) signed up, (ii) been approved, (iii) received dental care paid for through the benefit?

Q-2611² — April 29, 2024 — — With regard to the government's proposed plastics registry: (a) what is the projected cost to establish the registry and maintain it each year; (b) what is the timeline by which the government will implement the registry; and (c) did the government conduct any studies on the impact the registry will have on the price of food and other consumer products, and, if so, what are the details of each such study, including the findings and the website where the study can be found online?

Q-2612² — April 29, 2024 — — With regard to top secret security clearances provided by the government: how many employees or representatives of registered political parties currently have top secret security clearances, in total and broken down by party?

Q-2613² — April 29, 2024 — — With regard to the event named "Symposium: Building a Safe and Respectful Digital World" hosted at the Governor General's residence on April 11, 2024: (a) what were the costs associated with the event, in total and broken down by type of expenditure; (b) was this event initiated by the Governor General and her staff or officials, or by the Minister of Justice and Attorney General and his staff or officials; (c) on what dates did organizational or planning meetings take place in preparation for the event, and who was in attendance at each meeting; (d) were any government bills or initiatives highlighted during the event, and, if so, which ones; and (e) what specific action, if any, was taken by the Minister of Justice and Attorney General to ensure that the event did not put the Governor General in a partisan situation, and to stop any government legislation, initiatives or talking points from being promoted at the event?

Q-2614² — April 29, 2024 — — With regard to government engagement, association, or dealing in any other manner with social media influencers related to budget 2024 or any of the announcements leading up to the budget: (a) what are the names and handles of the influencers who were invited to (i) events on budget presentation day in Ottawa, (ii) government announcements or events in the month leading up to budget 2024; and (b) what are the amounts and details of all expenditures, in total, and broken down by influencer and type of cost the government incurred or expects to incur related to influencers, including, but not limited to, any payments being made to the influencers, travel costs, per diems, hospitality expenses, reimbursements for expenses incurred, honorariums, contracts, grants, monetary and non-monetary gifts, or any other type of incentive, financial or otherwise?

Q-2615² — April 29, 2024 — — With regard to government information about crime, broken down by year since 2016: how many suspects who were charged or deemed chargeable with homicide were on (i) bail or other type of remand, (ii) house arrest, (iii) parole, (iv) another type of community supervision, broken down by type, (v) an arrest warrant for a different crime, at the time they were charged or deemed chargeable?

Q-2616² — April 29, 2024 — — With regard to Canada's sanctions against the Russian Federation: (a) on what date was Airbus Canada granted a waiver to import titanium from the VSMPO-AVISMA Corporation; (b) which minister approved the waiver; (c) what was the rationale for the waiver; (d) who was consulted before the waiver was granted; (e) was the Ukrainian government informed before the waiver was granted, and, if so, when; (f) if the answer to (e) is negative, why not; and (g) has any other company in Canada been granted a waiver or waivers to Canada's sanctions regime against the Russian Federation since February 21, 2024, and, if so, what are the details, including the names of the companies?

Q-2617² — April 29, 2024 — — With regard to federal housing investments for Windsor, Toronto and Hamilton, since February 1, 2006, broken down by year and city: (a) how much federal funding was provided to support the construction of nonprofit or community housing and how many units were developed; (b) how much federal funding was provided to support the construction of cooperative housing and how many units were developed; and (c) how much federal funding was provided to support the construction of purpose-built rental housing and how many units were developed?

Q-2618² — April 29, 2024 — — With regard to Rent-Geared-Income (RGI) subsidies and operating subsidies funded by the Canada Mortgage and Housing Corporation (CMHC): (a) how many housing projects and units are currently receiving RGI subsidies funded by the CMHC, broken down by municipality, province or territory; (b) how many are receiving operating subsidies funded by the CMHC, broken down by municipality, province and territory; (c) is there an end or expiration date for the CMHC-funded RGI subsidies and operating subsidies for these housing projects/units and, if so, (i) what is the end date, (ii) how many units will lose the CMHC RGI subsidies broken down by (iii) municipality, province and territory, (iv) year; (d) what is the CMHC’s annual budget allocation for RGI subsidies, broken down by (i) municipality, province and territory, (ii) year since 1990; and (e) what is the CMHC’s annual budget allocation for operating subsidies, broken down by (i) municipality, province and territory, (ii) year since 1990?

Q-2619² — April 30, 2024 — — With regard to audits conducted by the Canada Revenue Agency (CRA), broken down by province or territory and fiscal year since 2015-16: (a) what is the total number of audits that determined a tax-payer had failed to withhold tax on rent paid to a non-resident landlord; (b) of the audits in (a), what is the total number of audits where (i) an adjustment resulting in more tax owing, (ii) an adjustment resulting in less tax owing, (iii) no adjustment, was made; (c) what is the total dollar value of payments received by the CRA as a result of the audits in (a); and (d) what were the total costs to the government related to 3792391 Canada Inc. v The King, 2023 TCC 37?

Q-2620² — April 30, 2024 — — With regard to federal housing investments for Vancouver Island, since February 1, 2006, broken down by year: (a) how much federal funding was provided to support the construction of non-profit or community housing and how many units were developed; (b) how much federal funding was provided to support the construction of cooperative housing and how many units were developed; and (c) how much federal funding was provided to support the construction of purpose-built rental housing and how many units were developed?

Q-2621² — April 30, 2024 — — With regard to the statement by the Minister of Justice and Attorney General of Canada in the House of Commons chamber on April 18, 2024 that, “In the budget, we have already announced that we are going to increase the maximum sentences for auto theft”, for each auto theft offence: (a) how many people have been convicted of each of the related offences since January 1, 2016, broken down by year and offence; (b) of those convicted in (a), how many offenders received the maximum sentence, broken down by year and offence; and (c) how many offenders have received the mandatory six months imprisonment for a third offence?

Q-2622² — April 30, 2024 — — With regard to government patronage, contracts and funding provided to the individuals who signed the document entitled "An Open Letter from Economists on Canadian Carbon Pricing": (a) which of the individuals who signed the document have received government contracts since November 4, 2015; (b) what are the details of all contracts in (a), including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the goods or services provided, (v) manner in which it was awarded (sole-sourced versus competitive bid); (c) what are the details of all grants or contributions issued to the signatories or the institutions they represent since November 4, 2015, including, for each, the (i) date, (ii) recipient, (iii) amount, (iv) purpose of the grant or contribution; and (d) which of the signatories has received an Order in Council appointment from the government or have served on any type of government advisory body since November 4, 2015, including, for each, the (i) name of the individual, (ii) body or organization for which they were appointed or served, (iii) position?

Q-2623² — April 30, 2024 — — With regard to the trip to Washington, D.C. by the Minister of Innovation, Science and Industry on April 27 and 28, 2024: (a) what was the minister's detailed itinerary on the trip; and (b) what are the details of each meeting attended by the minister on the trip, including the (i) date, (ii) time, (iii) purpose, (iv) list of attendees?

Q-2624² — April 30, 2024 — — With regard to the government's decision to decrease the amount of the carbon pricing revenues rebated for small businesses from 7% to 5%: (a) why is the government decreasing the percentages; and (b) on what date will the decrease take effect?

Q-2625² — April 30, 2024 — — With regard to Canada-wide Early Learning and Child Care Agreements, broken down by province or territory and by year, since October 1, 2019: what was the (i) total number of early learning and child care spaces available during the fiscal year, broken down by age group of child and type of setting, (ii) number of net new spaces created during the fiscal year, broken down by age group of child and type of setting, (iii) total number of inclusive spaces created or converted, broken down by age group of child and type of setting, (iv) average daily parental out-of-pocket fee for regulated child care spaces at the end of each fiscal year, (v) number of children 0 to K receiving fee subsidies, broken down by families receiving partial and full subsidies, (vi) number or proportion of child care service providers who provide services that are adapted to the needs of children with disabilities and children needing enhanced or individual supports, (vii) number and percentage of staff working in regulated child care programs who fully met the province's certification and educational requirements, (viii) annual public expenditure on training and professional development of the early childhood workforce, (ix) indicator data related to the wages of the early childhood workforce according to the categories of certification, including any wage enhancements, top-ups or supplements?

Q-2626² — April 30, 2024 — — With regard to the 2023 Canadian federal worker strike: (a) what was the total amount mistakenly paid out to striking employees; and (b) what is the amount that has not been collected back by the government?

Q-2627² — April 30, 2024 — — With regard to sole-sourced contracts entered into by the government related to products or services for ministers or their offices, including the Office of the Prime Minister, since January 1, 2019, broken down by each minister: what are the details of each such contract, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of goods or services?

Q-2628² — April 30, 2024 — — With regard to expenditures related to the Cabinet retreat which took place in Montréal, from January 21 to 23, 2024, including expenses incurred by the Privy Council Office as well as by other departments or agencies, and including travel expenses incurred by ministers, ministerial staff, and others: (a) what are the total expenditures related to the retreat incurred to date; (b) what is the breakdown of the expenditures by type of expense (accommodation, hospitality, audio-visual, etc.); (c) what are the details of all expenditures in excess of $1,000, including, for each, the (i) amount, (ii) vendor, (iii) description of the goods or services provided; and (d) what are the details of all travel expenses incurred by ministers and their staff, broken down by individual, including, for each, (i) the title, (ii) the amount spent on airfare, (iii) the amount spent on other transportation, (iv) the amount spent on accommodation, (v) the hotel or venue name, (vi) the amount spent on meals or per diems, (vii) other expenses, broken down by type?

Q-2629² — April 30, 2024 — — With regard to the Canadian Broadcasting Corporation (CBC): how much advertising revenue did the CBC receive from government departments, agencies, and other Crown corporations during the 2023-24 fiscal year?

Q-2630² — April 30, 2024 — — With regard to expenditures on public relations or media training, or similar type of services for ministers or their offices, including the Office of the Prime Minister, since March 1, 2022, and broken down by minister: what are the details of each such expenditure, including the (i) date of the contract, (ii) amount, (iii) vendor, (iv) individual providing the training, (v) summary of the services provided, including the type of training, (vi) person who received the training, (vii) date of the training?

Q-2631² — April 30, 2024 — — With regard to planned funding by the government related to "safe" or "safer" supply programs: how much does the government plan on spending on such programs, broken down by department, agency, and initiative in the current fiscal year and in each of the next five fiscal years?

Q-2632² — April 30, 2024 — — With regard to any arrangements the Canada Infrastructure Bank (CIB) has with banks or other financial institutions to back up their financing in the event that the CIB is dissolved: what are the details of any such agreements, or similar type of agreements that the CIB has entered into, including who the agreement is with, when it was signed, whether there is a cost to taxpayers, what collateral or guarantees are involved, and how much is being paid to each of the financial institutions?

Q-2633² — May 1, 2024 — — With regard to the Immigration, Refugees and Citizenship Canada Client Support Centre, in its Montreal offices: what is the number of (i) unilingual anglophone, (ii) bilingual, (iii) unilingual francophone, agents?

Q-2634² — May 1, 2024 — — With regard to the Royal Canadian Navy's Halifax-class frigates: (a) what is the number of (i) sea days, (ii) non-sea days, that each frigate has had for each of the last 48 months, broken down by month and by frigate; (b) what is the breakdown of the reasons for non-sea days, including the number of days each month that each frigate was not at sea for each of the reasons; and (c) what is the percentage of frigate fleet readiness each month for the last 48 months, broken down by month for the (i) total fleet, (ii) Pacific fleet, (iii) Atlantic fleet?

Q-2635² — May 1, 2024 — — With regard to the government's safe supply, safer supply and prescribed alternatives programs, broken down by year for the last two years: (a) which companies were allowed to import drugs into Canada that were to be used under the programs, broken down by drug that they were allowed to import; (b) how much of each drug was each company (i) allowed to import, (ii) importing, into Canada; and (c) what are the details of all contracts the government has had, or currently has, with companies related to providing drugs for the programs, including, for each, the (i) date, (ii) vendor, (iii) value of the contract, (iv) amount of drugs provided as part of the contract, in total and broken down by substance?

Q-2636² — May 1, 2024 — — With regard to government expenditures related to preparations for committee appearances by ministers, government officials, or representatives of any government department, agency, Crown corporation or other government entity, or for appearances by any former official, since January 1, 2019: what are the details of each expenditure, including the (i) date of the contract, (ii) vendor, (iii) description of goods or services, (iv) date of the committee appearance, (v) name and title of the individual or individuals appearing at committee, (vi) name of the committee, (vii) manner in which the contract was awarded (sole-sourced or competitive bid)?

Q-2637² — May 1, 2024 — — With regard to government dealings with Pollara Strategic Insights (PSI) since January 1, 2020: (a) what are the details of all contracts signed between government departments and agencies and PSI, including, for each, the (i) date, (ii) amount, (iii) description of goods or services, (iv) manner in which the contract was awarded (sole-sourced or competitive bid), (v) topics of research or polling covered by the contract, if applicable; (b) what are the details of each poll conducted by PSI for the government, including, for each, the (i) date, (ii) questions asked, (iii) results; and (c) what are the details of all meetings held between government officials, ministers or ministerial staff and PSI owner Don Guy, including, for each, the (i) list of attendees, (ii) date, (iii) location, (iv) purpose of the meeting?

Q-2638² — May 1, 2024 — — With regard to government dealings with economists Jim Stanford, Andrew Sharpe, Mostafa Askari, Mel Cappe, Marc Lévesque formerly of the Public Sector Pension Investment Board, Don Drummond, Kevin Milligan, Stephen Gordon, Andrew Leach, Paul Beaudry, Pierre Fortin, and Mike Moffat, since November 4, 2015: (a) which of the economists above have received government contracts; (b) what are the details of all contracts with these economists, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the goods or services provided, (v) manner in which it was awarded (sole-sourced versus or competitive bid); (c) what are the details of all grants or contributions issued to these economists, including, for each, the (i) date, (ii) recipient, (iii) amount, (iv) purpose of the grant or contribution; and (d) which of these economists have received an Order in Council appointment from the government or have served on any type of government advisory body since November 4, 2015, including, for each, the (i) name of the individual, (ii) body or organization for which they were appointed or served, (iii) position, (iv) start and end dates?

Q-2639² — May 1, 2024 — — With regard to Public Services and Procurement Canada and the “mPersona“ application: (a) what was the total amount paid to the 34 employees tasked to use the “mPersona” application created by Symaiotics; (b) what was the total amount paid to Symaiotics and any other company during the application’s trials, and, if there were other companies, how much was each company paid, broken down by company; and (c) how many hours did the 34 employees work on the application?

Q-2640² — May 1, 2024 — — With regard to firearms which were prohibited as a result of the May 1, 2020, Order in Council SOR/2020-96: (a) how many have been (i) turned in, (ii) seized, (iii) confiscated, (iv) otherwise obtained by the government broken down by how it was obtained; (b) what is the breakdown of (a) by those firearms which were previously in the possession of individuals versus businesses; and (c) what is the breakdown of (a) and (b) by make and model?

Q-2641² — May 1, 2024 — — With regard to the claim on page 29 of the 2024 budget document entitled “Tax Measures: Supplementary Information,” that the federal government returns more than 90% of direct proceeds from the fuel charge to individuals through the Canada Carbon Rebate: (a) what indirect or other proceeds from the carbon tax does the government receive; (b) how much money was received by the government in the last fiscal year from each of the indirect or other proceeds listed in (a); and (c) if the government does not track how much revenue it receives in indirect or other proceeds from the carbon tax, (i) why not, (ii) why does it make claims about people benefitting from the carbon tax knowing that it does not track this data?

Q-2642² — May 1, 2024 — — With regard to Crown-Indigenous Relations and Northern Affairs Canada's Northern Abandoned Mine Reclamation Program: (a) how much has been spent to date on the Giant Mine, in total and broken down by the (i) purpose, (ii) recipient, of the funding; (b) how much is allotted to each purpose and recipient in (a), in total and broken down by (i) purpose, (ii) recipient; and (c) what are the details of all consultant contracts for the Giant Mine and the Giant Mine Oversight Board, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the goods and services, (v) manner in which the contract was awarded (sole-sourced or competitive bid), (vi) start and end dates, if applicable?

Q-2643² — May 1, 2024 — — With regard to those fatalities and serious adverse events (SAEs) associated with Pfizer's and Moderna's COVID-19 mRNA-based vaccines and tracked by Health Canada (HC) and the Public Health Agency of Canada (PHAC): (a) did HC or the PHAC or any other federal agency or entity or agency contracted by the federal government detect a safety signal when examining, (i) the VAERS data from the USA, (ii) the EudraVigilance data from Europe, (iii) the Yellow Card data from England; (b) if the answer to (a) is affirmative for either (i), (ii) or (iii), what are the safety issues and how is the federal government addressing them; (c) what are the respective provincial numbers of vaccine-associated fatal and nonfatal heart attacks, strokes and other cardiovascular events recorded in Canada's vaccine surveillance program(s), between December 31, 2020 and December 31, 2023; (d) given the data from (c), has HC, the PHAC, or another federal government body such as the Canadian Institute for Health Information (CIHI) undertaken the research to determine if there has been an increase in the events described in (c) compared with their baseline values prior to the COVID-19 vaccine roll-outs; (e) what does the temporal association between the fatal or non-fatal serious adverse events in (c) and the timing of the mRNAbased vaccine roll-outs (primary series and boosters) show, per age group; (f) has the submission of any provincial health agencies' reports of vaccine-associated fatalities been denied by Canada's vaccine surveillance program(s); (g) if the answer to (f) is affirmative, how many reports of fatalities were denied by Canada's vaccine surveillance program(s) and for what reasons; (h) how many fatalities and SAEs associated with any drug or medical devices removes that item from the market; (i) how many fatalities and SAEs associated the mRNA-based vaccines will be deemed sufficient, as a threshold safety signal, to shut down the distribution of the mRNA products and what agency has established this benchmark; and (j) in consideration of cumulative reports of fatalities and SAEs during Pfizer's 3-month post-marketing phase, and in Canada and other jurisdictions around the world associated with the mRNA products, why was this vaccination program permitted to continue and who made that decision?

Q-2644² — May 1, 2024 — — With regard to the review by Health Canada (HC), the Public Health Agency of Canada (PHAC), or the National Advisory Committee on Immunization, of a pre-print study posted on October 15, 2023 of which six authors are associated with the US Food and Drug Administration that found "a new signal was detected for seizures-convulsions after BNT162b2 (2-4 years) and mRNA1273 COVID-19 vaccinations (2-5 years),": (a) which federal health agency, organization, committee or department(s) or outsourced contracted firm is responsible for reviewing or identifying studies such as the pre-print titled "Safety of Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID- 19 Vaccines in US Children Aged six months to 17 years;"; (b) has any federal health agency, organization, committee, department(s) or outsourced contracted firm reviewed or been made aware of the forementioned study or learned about the new safety signal of seizures/convulsions among children following monovalent COVID-19 vaccine; (c) if the answer to (b) is affirmative, has HC or any federal health agency, organization or committee issued any statement to the Canadian public or any communication to the provinces or the medical community to create awareness of this new safety signal; (d) if the answer to (c) is affirmative, what was the statement or communication provided; (e) if the answer to (c) is negative, why not; (f) how many episodes of seizures-convulsions have been reported in children under 17 years in Canadian Adverse Events following Immunization Surveillance System records, from (i) May 1, 2021 to April 30, 2023, (ii) May 1, 2018 to April 30, 2020; (g) what provincial and territory data is the federal government relying upon to monitor risk of seizures and convulsions in this cohort in real time; (h) how far out is the government monitoring this data (e.g. 28 days post-vaccine, up to 3 months, 6 months, 12 months, beyond 12 months post-COVID-19 immunization); (i) what are the Canadian government's threshold values for marking the likelihood of a vaccine serious adverse event as transitioning from an extremely rare, to a rare occurrence, and from a rare to a common occurrence; (j) what is the threshold whereby a safety signal of seizures or convulsions would shut down the mRNA vaccine program in children under the age of 17 years; (k) why are children's seizures-convulsions not listed on HC's webpage denoted to children's side-effects which was last updated on October 27, 2023; (l) with real-time monitoring, what other safety signals has HC, the PHAC or any other federal agency or department discovered post-mRNA vaccine injection for (i) children under age 5 years, (ii) children 6-17 years, (iii) persons 18-25 years, (iv) persons 26-35 years; (m) is HC receiving any data directly from provincial datasets to monitor increased usage of provincial health systems by Canadian children post-vaccination; (n) has any federal health agency or entity such as the Canadian Institute for Health Information or outsourced contractor tracked the number of episodes of myocarditis and pericarditis in young persons under the age of 35, post-vaccination, using billing or ICD-10 data from physicians and hospitals across Canada both before and after the COVID-19 injections had commenced; (o) if the answer to (n) is affirmative, (i) for what period of time post-immunization are they tracked, (ii) is the rate of myocarditis and pericarditis in persons under 35 years following the roll-out of the COVID-19 mRNA vaccines greater or less than the baseline rates of myocarditis and pericarditis from 2016-2019; (p) if there were deviations from the baseline found in (o)(ii), by how much did this occur and by which method has the determination of any difference, or lack thereof, been made; (q) if the answer to (n) is negative, why is this data not being tracked; and (r) when examining the risk-of-harm to benefit ratio of the COVID-19 mRNA products and when considering the combination of serious adverse events such as seizures-convulsions, myocarditis and pericarditis in young persons, what is the combined threshold of serious adverse events by which mRNA products would no longer be available to (i) children under the age of 5 years, (ii) children 6-17 years old, (iii) persons 18-25 years old, (iv) persons 26-35 years old, and who determines these thresholds, when, and based on what data?

Q-2645² — May 1, 2024 — — With regard to Correctional Service Canada, broken down by year since 2008: what is the capacity of federal institutions and the number of those incarcerated (i) in total, (ii) by region, (iii) by correctional institution?

Q-2646² — May 1, 2024 — — With regard to bonuses paid out at VIA HFR – Dedicated Project Office in the 2023-24 fiscal year: (a) what was the amount paid out in bonuses (i) in total, (ii) to executives; (b) how many individuals received payments; (c) what percentage of officials that received bonuses were (i) at or above executive level or equivalent, (ii) below the executive level or equivalent; (d) what is the average amount of payments (i) at or above executive level or equivalent, (ii) below the executive level of equivalent; and (e) what is the highest amount of payment?

Q-2647² — May 1, 2024 — — With regard to end-of-life marine vessel decommissioning and recycling, colloquially known as Shipbreaking, since January 1, 2016, broken down by year: (a) how many oversea tows of retired laker or coastal ships did Transport Canada approve; (b) how many of the oversea tows of retired lakers or costal ships that Transport Canada approved changed their final destination once in international waters; and (c) how many retired laker or costal ships were recycled in Canada?

Q-2648² — May 1, 2024 — — With regard to Health Canada (HC), the Public Health Agency of Canada (PHAC) and the reporting processes of adverse events following immunization (AEFI) and the implementation of the Brighton Collaboration Case Definitions of AEFIs: (a) in what ways does HC’s Canada Vigilance Program (CVP) differ from the PHAC’s Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) reporting system; (b) what purpose does it serve for Canada to have two reporting systems; (c) how, if at all, is the CVP and CAEFISS data amalgamated; (d) regarding HC’s relationship to the Brighton Collaboration (BC), (i) does one exist, and, if so, when did HC or the PHAC start using the BC criteria as a requirement for AEFI recognition, (ii) what is the BC’s purpose in the vaccine space in Canada; (e) regarding the implementation of the BC criteria, (i) when was it communicated to health care practitioners, (ii) how was it communicated; (f) were there any definitions of AEFIs that were changed after January 1, 2019 by (i) the BC, (ii) HC, (iii) the PHAC, (iv) the National Advisory Committee on Immunization; (g) if the answer to (f) is affirmative, (i) which ones were changed and by which agency, (ii) how were they changed, (iii) why were they changed; (h) is HC aware of the entities, such as the Coalition for Epidemic Preparedness Innovations, which partner with the BC; (i) if the answer to (h) is affirmative, what are those entities and corporations along with their inherent conflicts of interest (COI) in the vaccine space; (j) what or who are the other funding and non-funding entities who partner with the BC; (k) is HC aware of those individuals who constitute the BC’s Board of Directors and those who have been trained at the BC, including the members of the Advisory Committee on Causality Assessment; (l) if the answer to (k) is affirmative, (i) what percentage of those individuals are working, have worked, or have consulted for a pharmaceutical company, (ii) how many work in Canada; (m) of the individuals identified in (l) as Canadians, (i) what are their names, (ii) what are their conflicts of interest, (iii) what positions do they hold in other entities; (n) how much does the Government of Canada, and any entity related to the Government of Canada, provide monetarily to the BC; and (o) is the BC associated, either directly or indirectly, with any vaccine manufacturers or related organizations?

Q-2649² — May 1, 2024 — — With regard to the Canada Border Service Agency's (CBSA) releasing detainees, who would otherwise be held in custody pending deportation, due to a lack of detention capacity: (a) how long has the government known about the problem; (b) how many meetings has the government had on this issue; (c) what steps has the government taken to address this issue; and (d) how many detainees does CBSA project will have to be released due to lack of capacity?

Q-2650² — May 1, 2024 — — With regard to the government’s approach to the Chinese state owned CRRC Corporation Limited: (a) has the government identified any threats to national security from CRRC, and, if so, what are the details of each; (b) has the government identified any safety or performance issues with the operation of CRRC rolling stock in Canada, and, if so, what are the details of each; (c) since January 1, 2016, and broken down by year, how many projects involving CRRC have been approved by Transport Canada; and (d) since Canada joined the Asian Infrastructure Bank on March 19, 2018, is the government aware of (i) any CRRC projects that received funding from the Asian Infrastructure Bank, (ii) any other funds received by CRRC from the Asian Infrastructure Bank, and, if so, what are the details of each?

Q-2651² — May 2, 2024 — — With regard to Health Canada (HC) and the initial Pfizer-BioNTech mRNA product and approval process thereof: (a) did HC ask Pfizer to conduct genotoxicity studies to rule out insertional mutagenesis with DNA contamination; (b) if the answer to (a) is negative, why not; (c) what are the dangers with respect to insertional mutagenesis; (d) in the context of the mRNA vaccine, what is the purpose of the lipid nanoparticle (LNP) delivery system; (e) in the context of the mRNA vaccine manufacturing process, (i) what is the purpose of the SV40 enhancer-promoter-ori sequence, (ii) does it include a 72 base pair Nuclear Targeting Sequences (NTS), (iii) if the answer to (ii) is affirmative, what is the purpose of an NTS; (f) with regard to the plasmid map used in the production of the modified mRNA, (i) on what date did the manufacturer provide the map to HC, (ii) what gene annotation was provided; (g) in relation to (f), did the map contain an SV40 promoter-enhancer sequence and a reverse open reading frame; (h) if no plasmid map was received, why did HC not ask for one; (i) according to the response to Order Paper question Q-2266, “There are strict limits and controls for the presence of these residual fragments to ensure that there is no effect on the safety or effectiveness of the vaccine,” as part of the residual DNA testing and measurement, (i) what quantity of DNA fragments and SV40 enhancer-promoter fragments per dose were found in the Pfizer product, (ii) who provided the data to HC, (iii) when was this data provided to HC, (iv) is HC aware that the EMA reported a very large variance with respect to the residual DNA levels in the bulk mRNA and that the SV40 enhancer in the promotor sequence is 72 base pairs, (v) if the answers to (i) and (iv) are affirmative, what was HC’s appraisal of this information, (vi) what analytical techniques did the manufacturer rely upon to quantify the amount of RNA and the amount of DNA, (vii) do these quantities meet the “strict limits and controls for the presence of these residual fragments” and what are those limits; (j) as part of HC’s requirements for lot release testing, has HC independently confirmed the quantity of residual DNA and SV40 sequences in the Pfizer-BioNTech product; (k) if the answer to (j) is affirmative, (i) which laboratory and chief scientist provided this independent testing, (ii) what were the amounts recorded, (iii) were these different than those amounts provided by the manufacturer; (l) if the answer to (j) is negative, why was independent testing not completed; (m) is HC aware that Pfizer deliberately removed the SV40 enhancer sequence when reporting the annotated plasmid; and (n) according to HC's response to Order Paper question Q-2266, “The SV40 promoter enhancer sequence… is inactive, has no functional role, and was measured to be consistently below the limit," (i) who provided HC with this assessment, (ii) is there evidence that the SV40 promoter binds to the P53 tumor suppressor gene and affects DNA repair mechanisms, (iii) if the answer to (ii) is affirmative, what are the risks to the health of Canadians as a result?

Q-2652² — May 2, 2024 — — With regard to Health Canada’s standards for safety and efficacy for the COVID-19 vaccines: (a) have any COVID-19 vaccines met the requirements of Section C.08.001(2) of the Food and Drug Regulations (2)(g) and (2)(h) for safety and efficacy; (b) has any COVID-19 designated drug or vaccine, approved under Section C.08.001(2.1) of the Food and Drug Regulations, subsequently met the standard for safety and efficacy as delineated in subsection (2)(g) and (2)(h) of Section C.08.001(2); (c) if the answer to (b) is negative, why not; (d) if a COVID-19 designated vaccine has not met (2)(g) and (2)(h) of C.08.001(2), which requires the sponsor to establish safety and efficacy, can the use of the terms “safe and effective” be applied to these vaccines; (e) if the answer to (d) is affirmative, what is the rationale; (f) with regard to the portal on the approval of COVID-19 vaccines for Comirnaty and available information for COMIRNATY - Submission control number 252736 on the Government of Canada's website, is the information for 2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods available to the public under the transparency initiatives; (g) if the answer to (f) is negative, why not; (h) as the mRNA vaccines represent a new manufacturing platform, do they meet the requirements of Section C.04.015 of the Food and Drug Regulations; (i) if the answer to (h) is negative, why not; (j) have the Pfizer-BioNTech and Moderna vaccines been assigned to Group 2 Lot Evaluation Group as part of the Lot Release Program; and (k) if the answer to (j) is negative, why not?

Q-2653² — May 2, 2024 — — With regard to Report 5 (2024) of the Commissioner of the Environment and Sustainable Development to the Parliament of Canada: (a) how much has the Department of Agriculture and Agri-Food spent in the past five years on developing a climate change mitigation strategy; (b) how many employees were or are assigned to work on the strategy; and (c) how was the money spent, broken down by initiative?

Q-2654² — May 2, 2024 — — With regard to the Dairy Innovation and Investment Fund: (a) how many applications did the program receive; (b) how many of those applications were accepted; (c) how much of the total program funding was allotted to applicants; and (d) how much funding has been released to date, broken down by province?

Q-2655² — May 2, 2024 — — With regard to Immigration, Refugees and Citizenship Canada (IRCC) and the temporary public policy creating permanent resident pathways for Hong Kong residents since 2021, broken down by year: (a) how many individuals of Hong Kong origin have immigrated to Canada under the permanent residency program, broken down by (i) economic class migration, (ii) the family reunification program, (iii) the refugees and protected persons class, (iv) the "humanitarian and other" class, broken down by individualized stream; (b) how many individuals of Hong Kong origin have applied for permanent residency on "humanitarian and compassionate grounds" separately from the temporary public policy permanent residency pathways since 2021; (c) with regard to the temporary public policy, what is the breakdown of the application numbers since 2021 for (i) Stream A, (ii) Stream B, broken down by PR category; (d) of the figures in (c), how many applications were (i) approved, (ii) rejected, (iii) under review; (e) of the rejections in (d), what are the categorized reasons for rejecting the application, broken down by number; (f) of the cases under review and rejections in (c), what is the breakdown of the applications by (i) individual applications, (ii) family applications; and (g) of the approvals in (c), how many were tied to existing departmental quotas for the temporary public policy or the department's annual planned admission range per IRCC's annual report for permanent residency admissions under (i) economic class migration, (ii) the family reunification program, (iii) the refugees and protected persons class, (iv) the "humanitarian and other" class?

Q-2656² — May 2, 2024 — — With regard to Immigration, Refugees and Citizenship Canada (IRCC) and the open work permit pathway under a temporary public policy for Hong Kong residents: (a) what is the number of applications received by individuals of Hong Kong origin with "HKPPTR" inputted for the job title since the program was instituted in 2021; (b) of the applications in (a), how many were (i) accepted, (ii) rejected, (iii) under review; (c) of the rejections in (b), what is the breakdown of rejections by the location of the IRCC office or processing center; and (d) how many applications were rejected based on the lack of labour market impact assessment?

Q-2657² — May 2, 2024 — — With regard to the Immigration and Refugee Board of Canada (IRB): (a) what is the total number of adjudicators at the Refugee Protection Division; (b) of the adjudicators in (a), how many have postsecondary degrees, broken down by (i) office, (ii) type of degree; (c) of the adjudicators in (a), how many have previous tribunal experience; (d) of the adjudicators with prior tribunal experience, (i) what office do they work in, (ii) how many years of experience do they have, (iii) what year were they hired; (e) of the adjudicators in (a), how many have prior public service experience; (f) for each adjudicator with prior public service experience, (i) what office do they work in, (ii) how many years of experience do they have, (iii) what year were they hired; and (g) what was the essential qualification criteria required to be an adjudicator at the IRB in (i) 2011, (ii) 2012, (iii) 2015, (iv) 2020, (v) August 2021, (vi) November 2021, (vii) 2023?

Q-2658² — May 2, 2024 — — With regard to the 2024 budget documents: what are the expenditures incurred to date related to the documents, in total and broken down by (i) consulting costs, (ii) publishing costs, (iii) printing costs, (iv) design costs, including graphic design, (v) writing costs, (vi) marketing costs, (vii) any other costs not reflected in the previous categories?

Q-2659² — May 2, 2024 — — With regard to Section 5.25 of the Commissioner of the Environment and Sustainable Development's report entitled "Agriculture and Climate Change Mitigation - Agriculture and Agri-Food Canada": how does the government plan to meet its 3.5 Mt CO₂ eq fertilizer emission reduction target despite the shortfall stated by the Commissioner of the Environment and Sustainable Development in the aforementioned report?

Q-2660² — May 2, 2024 — — With regard to Section 5.24 of the Commissioner of the Environment and Sustainable Development's report entitled "Agriculture and Climate Change Mitigation - Agriculture and Agri-Food Canada": to achieve the fertilizer emission reduction targets, what voluntary agreements have been made between Agriculture and Agri-Food Canada and with fertilizer manufacturers, agricultural stakeholders, provinces, and farmers?

Q-2661² — May 2, 2024 — — With regard to Agriculture and Agri-Food Canada since January 2024: what is Agriculture and Agri-Food Canada's progress on developing a strategy to guide its climate change mitigation programs and activities?

Q-2662² — May 2, 2024 — — With regard to Exhibit 5.1 of the Commissioner of the Environment and Sustainable Development's report entitled "Agriculture and Climate Change Mitigation - Agriculture and Agri-Food Canada": (a) what was the methodology in determining the emissions of crop production; (b) what data gathering techniques were utilized; and (c) what were the earliest and latest data points that were used?

Q-2663² — May 2, 2024 — — With regard to Exhibit 5.1 of the Commissioner of the Environment and Sustainable Development's report entitled "Agriculture and Climate Change Mitigation - Agriculture and Agri-Food Canada": (a) what was the methodology in determining the emissions of animal production; (b) what data gathering techniques were used; (c) what were the earliest and latest data points that were used; (d) can the data be broken down by animal and by sector (e.g. beef, dairy, poultry); and (e) were meat processing facilities included in this data?

Q-2664² — May 2, 2024 — — With regard to Bill S-14, An Act to amend the Canada National Parks Act, the Canada National Marine Conservation Areas Act, the Rouge National Urban Park Act, and the National Parks of Canada Fishing Regulations: did any government department or agency do any consultations related to the proposed measures in the bill, and, if so, (i) who were the groups and people that were consulted, (ii) how much money was spent on the consultation process, (iii) what were the results or recommendations of the consultations, (iv) when were the consultations conducted, (v) how were the consultations conducted?

Q-2665² — May 2, 2024 — — With regard to Health Canada's (HC) review into the presence of SV40 and other DNA elements in the Pfizer COVID-19 vaccine: (a) what were HC’s concerns regarding "SV40 enhancer-promoter sequence and other non-essential sequences in Pfizer's plasmid for their COVID-19 vaccines" as noted in email correspondences between HC, European Medicines Agency (EMA) and the Food and Drug Administration officials in August 2023 prior to an ad-hoc Cluster meeting held on August 24, 2023; (b) what did HC ask of Pfizer to mitigate the concerns in (a), and what was Pfizer's response; (c) did HC's experts review Kevin McKernan's et al. study entitled “Sequencing of bivalent Moderna and Pfizer mRNA Vaccines reveals Nanogram to Microgram Quantities of Expression Vector dsDNA per Dose”; (d) if the answer to (c) is affirmative, (i) what were HC's summary conclusions, (ii) how did HC respond to those conclusions; (e) is HC still of the position that "there is no peer-reviewed scientific literature suggesting that the SV40 promoter-enhancer itself or the other non-functional elements pose a risk to human health"; (f) if the answer to (e) is negative, what key peer-reviewed scientific literature did HC consider noteworthy; (g) is HC aware of the ability of the SV40 promoter-enhancer to bind to P53 as demonstrated by Drayman et al.; (h) if the answer to (g) is affirmative, (i) was the risk communicated to Pfizer, (ii) what was Pfizer's response; (i) if the answer to (g) is negative, will HC perform a risk analysis to human health; (j) is HC aware of the ability of the SV40 enhancer to act as a nuclear targeting sequence as demonstrated by Dean DA, Dean BS, Muller S, Smith LC. in their study entitled “Sequence Requirements for Plasmid Nuclear Import”; (k) if the answer to (j) is affirmative, was the risk communicated to Pfizer and a response requested; (I) if the answer to (j) is negative, will HC perform an independent risk analysis to human health; (m) if Pfizer's vaccine did not contain unsafe or unexpected plasmid sequences, such as SV40 promoter-enhancer, then why, on August 29, 2023, did Michael Wall state in an email to Tong Wu, "Health Canada will continue to work with international regulatory partners to achieve harmonisation regarding removal of these sequence elements from the plasmid for future strain changes"; (n) what are the "sequence elements" to which Michael Wall was referring; (o) regarding an email, on October 12, 2023, from an EMA colleague to Dr. Dean Smith at HC, which stated "We are going to discuss the matter of SV40 with Pfizer-BioNtech as well as these alleged high level of DNA in vaccines coming from these external parties. Have you taken any action? What would be your perspective?", (i) what action was taken or will be taken to address the "alleged high level of DNA" referenced in the email, (ii) has any action been taken to date, and, if so, what; (p) has HC informed (i) the Public Health Agency of Canada, (ii) Dr. Howard Njoo, (iii) Dr. Theresa Tam, (iv) Dr. Supriya Sharma, (v) the National Advisory Committee on Immunization, (vi) any or all of the provincial or territorial Chief Medical Officers, of the presence of the SV40 enhancer-promoter and DNA fragments; (q) if the answers to (p)(i) to (p)(vi) are affirmative, what were their individual responses; (r) if the answers to (p)(i) to (p)(vi) are negative, why or why not; (s) what risk assessment did HC perform to determine that SV40 promoter-enhancer is safe in an mRNA vaccine within the unique LNP delivery system; (t) what other Canadian vaccines contain SV40 promoter-enhancer sequence; and (u) what is HC's policy about SV40 promoter-enhancer being in any vaccine product?

Q-2666² — May 2, 2024 — — With regard to the government's appointment of Catherine Blewett to be Secretary of the Treasury Board, effective February 6, 2024: (a) since February 6, 2024, broken down by month, how many days did the Secretary work in person at the Treasury Board Secretariat's main office at 90 Elgin Street in Ottawa; and (b) is the Secretary exempt from the government's requirement that employees are to work in the office for at least two days per week?

Q-2667² — May 2, 2024 — — With regard to Exhibit 5.8 of the Commissioner of the Environment and Sustainable Development's report entitled "Agriculture and Climate Change Mitigation-Agriculture and Agri-Food Canada" and the performance targets related to climate change mitigation in place for the Agricultural Clean Technology program: (a) what were the 193 new technologies adopted based on 141 performance reports; (b) what did the performance reports say about the adoption of these technologies; and (c) what were the 352 approved projects based on 141 performance reports?

Q-2668² — May 2, 2024 — — With regard to Health Canada's (HC) signing of the contract with Pfizer on October 26, 2020, and the subsequent release of the Pfizer mRNA COVID-19 vaccine to the Canadian public: (a) was HC aware of a presentation made to the Vaccines and Related Biological Products Advisory Committee on October 22, 2020, where Dr. Steve Anderson at the US Food and Drug Administration's Center for Biologics Evaluation and Research, presented "Plans for Monitoring COVID-19 Vaccine Safety and Effectiveness"; (b) if the answer to (a) is affirmative, did HC review the presentation deck, specifically slide #16, which identified a working list of 22 "possible adverse event outcomes", including acute myocardial infarction, stroke, myocarditis, pericarditis and death; (c) if the answer to (a) is negative, at what point did HC become aware of this presentation material or these serious adverse events of special interest; (d) once HC was in possession of this information, where and when did HC publish this list of 22 "possible adverse event outcomes" for the purpose of informing (i) the general public, (ii) medical physicians and hospitals, (iii) the media; (e) how did HC plan to independently and actively monitor these 22 "possible adverse event outcomes"; (f) did the initial Pfizer monograph posted on HC's website on December 9, 2020, and the ones posted thereafter identify any of these 22 "possible adverse event outcomes"; (g) when Pfizer vaccines were first being administered in early 2021, did HC require the sponsor to include a package insert in each mRNA vaccine vial containing a fully printed monograph of the product's ingredients and side effects including the identified 22 "possible adverse event outcomes" for both the consumer and the health professional to ensure full, informed consent; (h) if the answer to (g) is negative, (i) why was this not required, (ii) how was full, informed consent achieved at the time of vaccination; (i) did HC plan to actively monitor and publish the 1,291 "serious adverse events (SAEs) of special interest" which were contained in the Appendix of Pfizer's report of April 30, 2021, entitled "5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021" to ensure medical awareness of these potential SAEs; (j) if the answer to (i) is affirmative, (i) how were the SAEs monitored, (ii) what information was gathered; and (k) if the answer to (i) is negative, why are the 1,291 SAEs of special interest being monitored by the US Food and Drug Administration and not by HC?

Q-2669² — May 2, 2024 — — With regard to the post-market surveillance used by Health Canada (HC) to monitor for safety concerns regarding the novel COVID-19 vaccine products: (a) have HC, the Public Health Agency of Canada (PHAC), Statistics Canada or any other federal agency or entity, department, or third-party agency used databases such as the Institute for Clinical Evaluative Sciences, the Ontario Health Data Platform or any other databases that collect realtime data to determine an individual's date of medical diagnoses, including death; (b) if the answer to (a) is affirmative, what are the anonymized individual results for the following new onset diagnoses, from December 1, 2020, to the present date, cross referenced with the date of receipt of COVID- 19 vaccine, the age by 5-year increments, the gender, and the province or territory of residence, (i) cerebral infraction, (ii) cerebral hemorrhage, (iii) sudden infant death syndrome, (iv) seizure, (v) acute myocarditis, (vi) pericarditis, (vii) transverse myelitis, (viii) miscarriage, (ix) Bell's palsy, (x) pancreatic cancer, (xi) esophageal cancer, (xii) anaphylaxis, (xiii) myocardial infraction, (xiv) breast cancer, (xv) pulmonary embolism, (xvi) deep vein thrombosis, (xvii) thrombocytopenia, (xviii) pulmonary hypertension (xix) lymphoma, (xx) ruptured aortic aneurysm, (xxi) cellulitis, (xxii) Guillain Barre syndrome, (xxiii) stillbirth, (xxiv) encephalopathy due to vaccination, (xxv) encephalopathy, (xxvi) sudden death, (xxvii) preeclampsia, (xxviii) premature birth, (xxix) multiple sclerosis, (xxx) hysterectomy, (xxxi) vasculitis; (c) what are the quarterly incidence rates of the diagnoses in (b) categorized by (i) age with 5-year increments, (ii) gender, (iii) province or territory of residence from January 1, 2014, to November 30, 2020; (d) if the answer to (a) is negative, what are the quarterly incidence rates of the diagnosis in (b) from December 1, 2020, to the present day, categorized by (i) age with 5-year increments, (ii) gender, (iii) province or territory of residence; (e) if the answer to (a) is affirmative, has this data been used to compare rates of medical diagnosis between never COVID-19 vaccinated individuals and others based on the number of COVID-19 injections received; (f) if the answer to (a) is affirmative, has this data been used to determine the length of time between receipt of a COVID-19 vaccine and the medical diagnosis or death, and, if so, what are the ranges of time; (g) if the answer to (a) is affirmative, will the raw data be released to independent researchers; (h) if the answer to (a) is negative, will the government make the raw anonymized data public; (i) if the answer to (a) is negative, what plans are either in place or planned to complete such an analysis in order to validate adverse event reporting systems that may be outdated for the COVID-19 vaccine products; (j) have there been any communications from or between HC, the PHAC, Statistics Canada, or any other federal agencies or their representatives about the Institute for Clinical Evaluative Sciences, the Ontario Health Data Platform, or any other similar database sources that capture receipt of COVID-19 vaccine(s) or booster(s) and clinical outcomes to monitor for safety signals; (k) if the answer to (j) is affirmative, which government agencies or out-sourced third parties were involved, and, for each, (i) what are the communications, (ii) who directed these communications, (iii) what were the dates of these communications, (iv) what was included in these communications, (v) what were the conclusions of these communications?

Q-2670² — May 2, 2024 — — With respect to Health Canada's (HC) review into the presence of SV40 and other DNA elements in the Pfizer COVID-19 vaccine: (a) in July 2023, what was the basis for an Issue Analysis Summary (IAS) for the SV40 promoter agreed to by Drs Co Pham, Tong Wu and Michael Wall; (b) in July 2023, what was the rationale for HC to submit #1 Clarifax request to Pfizer and (i) what was the outcome of this request, (ii) did the response from the sponsor to #1 Quality Clarifax address all of HC's questions and concerns, and, if negative, what was missing, (iii) did Pfizer provide a complete justification for the SV40 sequences, (iv) did Pfizer provide an updated fully annotated table of functional elements of the plasmid, (v) did Pfizer include non-functional elements of the plasmid in the annotated table specifically addressing any unexpected open reading frames and other sequence elements, (vi) if the answer to (iii), (iv) and (v) is affirmative, what were the results, (vii) if the answer to (iii), (iv) and (v) is negative, what was HC's response; (c) with respect to the quantitative assay used to measure the residual DNA in order to confirm the presence of the SV40 promoter-enhancer, did HC confirm with Pfizer (i) the amplicon size used, (ii) the appropriateness of the primers used; (d) if the answer to (c) is affirmative, what was Pfizer's response; (e) if the answer to (c) is negative, has HC independently verified the total amounts of residual DNA, the appropriateness of the primers, and the amplicon size used by Pfizer to measure the residual DNA in the XBB.1.5 vials; (f) with respect to Pfizer's response in #1, #2 and #3 Quality Clarifaxes, did Pfizer provide the requested information on the fragment size analysis by December 1, 2023; (g) if the answer to (f) is affirmative, what were the results; (h) if the answer to (f) is negative, what was HC's response; (i) concerning the residual plasmid DNA in the drug substance, (i) did Pfizer provide the requested information on the characterization of residual circular DNA plasmid by December 1, 2023, (ii) did Pfizer provide the requested information on the risk of replication in bacterial cells by December 1, 2023, (iii) did HC at any time request information on the risk of replication in mammalian cells; (j) if the answer to (i)(i), (i)(ii) and (i)(iii) is affirmative, what were the results; (k) if the answer to (i)(i), (i)(ii), and (i)(iii) is negative, what was HC's response; (I) did HC request that Pfizer repeat the analyses for fragment size distribution and residual DNA for any of Pfizer COVID-19 vaccines (i.e., original or bivalent); (m) if the answer to (l) is affirmative, what were the findings; (n) if the answer to (l) is negative, why not; (o) did HC independently verify the quantity of residual DNA, the size distribution and the presence of SV40 sequences in the XBB.1.5. vaccine, or any other COVID-19 vaccine submitted by Pfizer for review; (p) at any time, did Pfizer ever suggest that the regulatory sequence elements in question were functional with respect to the manufacturing process, and, if so, what was the function; (q) at any time, did Plizer ever suggest that regulatory sequence elements in question were functional following inoculation into humans; and (r) if the answer to (p) is affirmative, what and when did Pfizer inform HC?

Q-2671² — May 2, 2024 — — With regard to the arrangements and travel costs for all government press briefings and pre-budget announcements in the lead-up to the tabling of the federal budget and to highlight the measures to be contained in the budget: what were the expenses and costs incurred from March 4, 2024, to April 16, 2024, the day of the budget speech, broken down by type of announcement, by date, by location and by the ministers, parliamentary secretaries and political staff present?

Q-2672² — May 2, 2024 — — With respect to Canada’s Vaccine Injury Support Program (VISP): (a) how many claims have been filed to the program from December 8, 2020, to present day, broken down by age group; (b) how many of those claims have been approved, broken down by age group; (c) of the approved claims, what have been the diagnoses and their frequencies, broken down by age group, date approved, and the corresponding COVID-19 vaccines that were administered; (d) of the approved claims, what are the percentages of Canadians who received (i) the AstraZeneca COVID-19 vaccine, (ii) the J&J COVID-19 vaccine, (iii) any COVID-19 vaccine produced by Pfizer-BioNTech, (iv) any COVID-19 vaccine produced by Moderna, (v) a combination of COVID-19 vaccines; (e) how many persons have received compensation to date through the VISP; (f) what is the total compensation to date given to vaccine-injured Canadians; (g) what is the age of the youngest person who received funding support approval through the VISP, and their associated diagnosis; (h) for all death claims, (i) what is the total number of death claims that have been filed to VISP, (ii) of the total, what have been the underlying causes of death, aside from the vaccine and their frequencies, (iii) how many filed death claims have been approved by the VISP and their corresponding diagnosis and vaccine status; (i) did the VISP require autopsies prior to approving a death claim; (j) if the answer to (i) is affirmative, what immunohistochemistry requirements does the VISP specify for these autopsies; (k) when denied, how many persons have appealed their claim and how many have been successful; (l) regarding the determination of causality of the adverse event in relation to a COVID-19 vaccine, (i) what is the standard criteria, (ii) does the Medical Review Board take into consideration the Bradford Hill criteria; (m) what are the professional qualifications of each member on the Medical Review Board; and (n) who are the professionals on the Medical Review Board?

Q-2673² — May 2, 2024 — — With regard to the COVID-19 Therapeutics Task Force (TTF) who oversaw submissions for grant funding from Innovation, Science and Economic Development Canada (ISED)’s Strategic Innovation Fund: (a) in total, how many projects were considered for funding; (b) with respect to the projects which were funded, (i) how many received funding, (ii) how much funding was allocated per project, (iii) which drugs were being investigated per each approved project, (iv) what was the total amount of funding granted for the approved projects; (c) with regard to the projects which were not approved for funding, what recommendations were made to them; (d) with regard to the therapeutics which were recommended for purchase, (i) what were these therapeutics, (ii) were these therapeutics purchased, (iii) what was the implementation plan, (iv) if there was no plan, why not; (e) were the drugs Ivermectin or Hydroxychloroquine considered by the TFF; (f) if the answer to (e) is affirmative, what were their recommendations and how did they arrive at them; (g) who were the members of the TTF; (h) were any of the members pharmacists, pharmacologists, or toxicologists; (i) what were the members' conflicts of interest; (j) did any of the members withdraw from the task force prior to its conclusion; (k) if the answer to (j) is affirmative, who left early and why; (l) regarding the document entitled “HEALTH CANADA/ PUBLIC HEALTH AGENCY OF CANADA MEMORANDUM TO THE MINISTER OF HEALTH, Meeting with the COVID-19 Therapeutics Task Force” dated February 24, 2021, and signed by the President of the Public Health Agency of Canada and the Deputy Minister of Health, which reads that “At the previous meeting TTF members expressed concern that their mandate was ending. TTF members were specifically concerned about what they felt was insufficient attention to therapeutics, failures of implementation, and the need to be forward looking for surveillance of upcoming therapeutic opportunities. It is expected that TTF members will raise these concerns to you”, (i) what concerns were raised to the signee, (ii) what documents were provided with respect to expressing those concerns; and (m) when and why was the TTF mandate ended?

Q-2674² — May 2, 2024 — — With regard to federal housing investments in Edmonton, since February 1, 2006, broken down by year: (a) how much federal funding was provided to support the construction of nonprofit or community housing and how many units were developed; (b) how much federal funding was provided to support the construction of cooperative housing and how many units were developed; and (c) how much federal funding was provided to support the construction of purpose-built rental housing and how many units were developed?

Q-2675² — May 3, 2024 — — With regard to the government’s announcement on August 12, 2021 to invest $1.44 billion into Telesat’s advanced low Earth orbit (LEO) satellite constellation, Telesat Lightspeed: (a) what are the details of government purchases or sales of Telesat equity or shares since the announcement, including, for each, the (i) date, (ii) total price or amount, (iii) type of transaction (bought or sold), (iv) number of shares or percentage of equity, (v) share price, if applicable; and (b) what is the government’s current equity stake in Telesat in terms of value, percentage of equity, and number of shares?

Q-2676² — May 3, 2024 — — With regard to the Court Challenges Program: (a) how much money has been delivered through the program in each of the last five years; (b) who has received money through the program, and how much was received; and (c) if the government refuses to answer (b) citing solicitor-client privilege, what is the government's rationale given that it is neither the solicitor nor the client in many of the related court cases?

Q-2677² — May 3, 2024 — — With regard to federal infrastructure funding, since January 1, 2016, broken down by year: (a) how much money has been distributed for infrastructure projects under the (i) Rural Transit Solutions Fund, (ii) Zero Emission Transit Fund, (iii) Active Transportation Fund, (iv) Green and Inclusive Community Buildings Program, (v) Natural Infrastructure Fund, (vi) Canada Healthy Communities Initiative; (b) what are the details of all projects in (a), including, for each, (i) the project description, (ii) the date of the funding announcement, (iii) the amount of funding originally announced, (iv) the amount of funding distributed to date, (v) the date the funding was transferred to the recipient, (vi) the recipient of the funding, (vii) the current status of the project, (viii) the project location, (ix) whether the location of the project is a Census Metropolitan Area or Census Agglomeration, (x) the original projected completion date for the project, (xi) the actual completion date for the project, if applicable, (xii) the current projected completion date for the project, (xiii) the reason for the project delay, if applicable; and (c) what are the details of any infrastructure funding which was announced, but for which the related project was later cancelled, including, for each, the (i) project name and description, (ii) project location, (iii) amount of funding originally announced, (iv) amount of funding transferred to the recipient, (v) date of the cancellation, (vi) reason for the cancellation?

Q-2678² — May 3, 2024 — — With regard to the Disability Tax Credit (DTC), broken down by fiscal year from 2015-16 to 2023-24: (a) what is the total number of people that applied to claim the DTC, broken down by basic activities of daily living (BADL); (b) what is the total number and percentage of approved DTC claims, broken down by BADL; (c) what is value of DTC claims broken down by BADL; (d) what is the number and percentage of new applications processed and accepted, broken down by BADL, and how many of those approved (i) had eligibility for the DTC for five years or more, (ii) expired after a certain number of years; (e) what is the number and percentage of new applications processed and rejected, broken down by BADL; (f) what was, or is, the total budget for all OTC-related operations; (g) what was, or is, the total employee count for all OTC-related operations, and what is the number of medical practitioners working on the DTC; (h) how many days, on average, did the Canada Revenue Agency (CRA) take to assign a DTC application for review from the time of filing by the applicant; (i) how many days, on average, did the CRA take to mail (electronic or otherwise) a notice of determination related to a DTC application; (j) how many letters or correspondences did CRA send to the relevant medical practitioners asking for more information related to DTC applications received; (k) how many DTC applicants that were rejected or denied (i) requested a review of their application, (ii) challenged the CRA's decision by filing an income tax objection, (iii) moved beyond the CRA to an appeal filed to the Tax Court of Canada; (I) how long does the CRA take to review an application as noted in (k), (i) how many of those reviews resulted in an application being accepted; and (m) does the CRA have a dedicated telephone or TTY line for DTC applications, and (i) if so, how many calls has it received, (ii) if not, why not?

Q-2679² — May 3, 2024 — — With regard to the Select Luxury Items Tax (luxury tax) that came into effect on September 1, 2022: (a) what is the number of (i) aircrafts, (ii) vehicles, (iii) vessels, that were reported under the luxury tax, broken down by province and territory; (b) how many applications, registrations, forms, returns, and other documentation does the Canada Revenue Agency (CRA) have associated with the luxury tax, including those seeking exemptions, for taxpayers, including the full title of each piece of documentation; (c) what has been the total cost to the CRA to implement and administer the luxury tax to date; (d) what are the total amounts submitted to the CRA by taxpayers to date under (i) Part D, (ii) Part E, (iii) Part F, of Form B500; and (e) what are the total amounts submitted to the CRA by taxpayers to date under (i) Part D, (ii) Part E, (iii) Part F, of Form B501?

Q-2680² — May 3, 2024 — — With regard to the Climate Action Incentive Fund (CAIF), broken down by province and year: how much money was returned through the CAIF’s Municipalities, Universities, Schools and Hospitals Retrofit stream, broken down by (i) municipality, (ii) university, (iii) school, (iv) hospital?

Q-2681² — May 3, 2024 — — With regard to federal infrastructure funding under the Investing in Canada Plan, since January 1, 2016, broken down by year: (a) how much money has been announced for projects located in (i) Census Metropolitan Areas (CMAs), (ii) Census Agglomerations (CAs), (iii) areas outside of CMAs or CAs; (b) how much money has been distributed for projects located in (i) CMAs, (ii) CAs, (iii) areas outside of CMAs or CAs; (c) what are the details of each project in (a) and (b), including the (i) name of the CMA the project is located in, if applicable, (ii) name of the CA the project is located in, if applicable, (iii) name of the region the project is located in, if applicable, (iv) project description, (v) amount of funding originally announced, (vi) amount of funding distributed to date, (vii) date the funding was transferred to the recipient, (viii) recipient of the funding, (ix) current status of the project, (x) original projected completion date for the project, (xi) actual completion date for the project, if applicable, (xii) current projected completion date for the project, (xiii) reason for the project delay, if applicable; and (d) of the funding announced for projects in (a), were any projects later cancelled, and, if so, what are the details of each, including the (i) name of the CMA the project is located in, if applicable, (ii) name of the CA the project is located in, if applicable, (iii) name of the region the project is located in, if applicable, (iv) project description, (v) amount of funding originally announced, (vi) amount of funding transferred to the recipient, (vii) date of the cancellation, (viii) reason for the cancellation?

Q-2682² — May 3, 2024 — — With regard to the M-KOPA project that received financing through the Development Finance Institute Canada (FinDev Canada), a Canadian Crown corporation that is a subsidiary of Export Development Canada (EDC): (a) what assessments has EDC made to ensure that M-KOPA is properly accounting for all expenditures of taxpayer funds provided by the Government of Canada; (b) has the government reviewed and analyzed any of the expenditures by M-KOPA through FinDev Canada and EDC, and, if so, what are the details of all written, electronic and other documents pertaining to M-KOPA and funds provided to this organization; (c) has any auditing been done of M-KOPA or of FinDev Canada in relation to M-KOPA, and, if so, what were the findings; (d) what was the timeline for the approval of investments made by the Government of Canada, through EDC to FinDev Canada then to M-KOPA; and (e) what are the details of all memorandums and briefing notes about M-KOPA, all financial and contractual details including all memorandums and briefing notes and scope documents and economic impact analysis as well as all other financial documents related to M-KOPA that were sent or received by EDC, FinDev Canada, or any relevant ministerial offices and ministers, deputy ministers, assistant deputy ministers, the Minister of Finance, the Prime Minister and the Office of the Prime Minister, the Privy Council Office, and any other outstanding documentation that discusses the provision of funding or potential funding and screening of M-KOPA from 2016 to 2024?

Q-2683² — May 3, 2024 — — With regard to the recently announced emissions cap on Canada's oil and gas sector: (a) what assessments has the Government of Canada made regarding the economic impact on Gross Domestic Product and Export amounts, by dollar, for Canada; (b) has the government analyzed and reviewed the potential impact to Canadian firms that export energy products, and, if so, what are the details; (c) has the government considered the potential economic fallout in terms of job losses across the energy sector, at the provincial and territorial level, and, if so, what were the findings; (d) prior to the announcement of the emissions cap, did the government engage in any public relations or briefings with non-government organizations (NGO), the United Nations, and any sub-directorates of the United Nations at the ministerial level, and, if so, what was the nature of those discussions and the result of those discussions; (e) did the government procure any NGO or outside-of-government entities or actors to raise the subject within the Canadian media sphere, and, if so, who was involved and how much money was spent on these endeavors; and (f) what are the financial and contractual details of all memorandums and briefing notes, scope documents and economic impact analysis about the emissions cap that were sent to, or received by, the Minister of Export Promotion, International Trade and Economic Development, the Minister of the Environment and Climate Change, and the Minister of Finance, as well as any relevant ministerial offices and other involved ministers, deputy ministers, assistant deputy ministers regarding the emissions cap policy file, from 2016 to 2024?

Q-2684² — May 3, 2024 — — With regard to the Canada Revenue Agency and write-offs of accounts receivable, broken down by fiscal year from 2015-16 to 2023-24: (a) what was the total amount of write-offs; (b) how many (i) individual taxpayers, (ii) corporations, had amounts written-off; (c) what was the average amount written-off for (i) individual taxpayers, (ii) corporations; (d) what was the dollar amount of the single largest write-off, broken down by the (i) Financial Administration Act, (ii) Bankruptcy and Insolvency Act, (iii) Income Tax Act, (iv) Excise Tax Act; and (e) what was the dollar amount of the single largest write-off for (i) an individual taxpayer, (ii) a corporation?

Q-2685² — May 3, 2024 — — With regard to the Treasury Board Secretariat (TBS) hybrid workforce model for the federal public service: (a) has the TBS ever sought the opinion of the Office of the Privacy Commissioner of Canada regarding the concern for and risk of privacy and data breaches of sensitive and confidential information of Canadian citizens that may be caused with malicious intent such as a cyberattack, accident, or negligence, and, if so, when was the opinion sought and what was the opinion; and (b) is the TBS aware of any privacy and data breaches that have occurred with federal workers operating off-site since March 16, 2020, as a result of working from home on unsecured networks, devices, software, or hardware, and, if so, what are the details of each breach including for each the (i) date, (ii) department or agency involved, (iii) summary of what occurred, (iv) number of individuals whose information was impacted, (v) type of information breached, (vi) length of time until the breach was resolved, (vii) details on if and how those whose information was breached were notified, (viii) date on which the Privacy Commissioner was notified, if applicable?

Q-2686² — May 3, 2024 — — With regard to the Known Traveller Digital Identity (KTDI) project announced by the government in January 2018 and the successor pilot on Digital Travel Credentials (DTCs): (a) what is the current status of both projects; (b) why was the decision made to not resume the KTDI; (c) how was the data, including personal data, that was obtained through the KTDI used; (d) was the data, including personal data, that was obtained through the KTDI retained, and, if so, by whom, including the country, territory, organization, and company details, including (i) which types of data were retained, (ii) where is the data stored; (e) what is the nature of the government's involvement, including its agencies, in the new DTC project; (f) what is the World Economic Forum’s involvement in the new project, if any; (g) who are the project partners; (h) what is the end date of the DTC project; (i) how many Canadian travellers opted into the project to date; (j) for travellers who have been participating in the project, what type of data was shared with (i) the government, (ii) third parties; (k) what third parties received the data in (j)(ii); (l) what specific technologies is the government testing, and what are the parameters around that testing; (m) what (i) benefits of, (ii) problems with, the technologies have been identified to date; and (n) what are the total government expenditures related to the KTDI and DTC projects since 2018, broken down by type of expenditure?

Q-2687² — May 3, 2024 — — With regard to government information on weather modification activities in Canada since 2015: (a) what weather modification activities is the government aware have taken place, including, but not limited to, cloud seeding or modification, hail suppression, fog dissipation, precipitation modification, lightning modification, hurricane seeding; (b) what are the (i) start and end dates of the activities in (a), (ii) stated objectives, (iii) geographic areas affected; (c) what techniques, chemicals and equipment are involved in each of the known weather modification activities; (d) is the government aware of any unlawful or disputed weather modification activities in Canada, and, if so, what are the details including the dates and summaries of each activity; (e) what, if any, government support or funding is provided to any of the activities in (a); (f) which government departments or agencies are involved in activities in (e), and what are the program objectives and research areas; (g) which, if any, international entities are involved in any of the activities; and (h) what outcomes and impacts have been observed by these activities and the methods and chemicals employed, including impacts on the environment, storm severity, and any other impacts?

Q-2688² — May 3, 2024 — — With regard to the Universal Broadband fund, broken down by year and province or territory: how much money did the fund disperse and how much money went to (i) Rogers, (ii) BCE, (iii) Telus, or its subsidiaries?

Q-2689² — May 3, 2024 — — With regard to the electoral district of Churchill—Keewatinook Aski, broken down by fiscal year since 2005-06: what are the details of all federal infrastructure investments, including direct transfers to municipalities, regional district associations or First Nations, national parks, highways, etc.?

Q-2690² — May 3, 2024 — — With regard to Canada’s participation in the World Economic Forum Annual Meeting in Davos, Switzerland, from January 15 to 19, 2024: (a) how many individuals were part of Canada’s delegation; (b) who were the members of the delegation, including, for each, their (i) name, (ii) title, (iii) role; (c) what are the details of all meetings held in Davos involving the Deputy Prime Minister, including, for each, the (i) date, (ii) names and titles of the attendees, (iii) purpose of the meeting, (iv) agenda items, (v) summary of what occurred at the meeting, including any agreements made; (d) what are the details of all meetings held in Davos involving members of the Canadian delegation other than the Deputy Prime Minister, including, for each, the (i) date, (ii) names and titles of the attendees, (iii) purpose of the meeting, (iv) agenda items, (v) summary of what occurred at the meeting, including anything that was agreed to; (e) what are the details, including the summary of terms, of any agreements entered into during the forum; (f) what are the details of all follow-up action taken by the government as a result of what happened at the forum; (g) what are the details of all memoranda or briefing notes prepared to support Canada’s delegation to the forum, including, for each, the (i) date, (ii) sender, (iii) recipient, (iv) title, (v) subject matter, (vi) summary of contents, (vii) file number; and (h) what was the total cost to the taxpayer, broken down by category of expense?

Q-2691² — May 3, 2024 — — With regard to the Canada Infrastructure Bank's (CIB) investment in the Avenue Living residential retrofits: (a) what is the summary of the terms of the project agreement with Avenue Living; (b) which properties are undergoing retrofits financed by the CIB; (c) at which properties is the CIB aware of significant rent increases since the financial close of the agreement; (d) how much of the investment has been disbursed to date and how has that financing been disbursed; (e) what is the current status of each of the retrofit projects at Avenue Living properties; (f) what measures did the CIB take when the investment agreement was made to ensure the investment would not be used as a rationale to increase rent; (g) if the answer to (f) is none, why were no measures taken; (h) what, if any, changes to the agreement will the CIB make in light of the rent increases at some properties; and (i) what changes is the CIB implementing to ensure its financing of retrofits do not result in rent increases at rental properties?

Q-2692² — May 3, 2024 — — With regard to Canada Revenu Agency registered charities: (a) which charities that had Israeli nationals as agents or intermediaries had their status revoked due to a failed audit between 2017 and 2023; (b) which charities that had Israeli nationals as agents or intermediaries failed audits between 2017 and 2023 and did not have their status revoked; (c) what are the internal rules, regulations, and protocols around revocation of charity status with regard to both domestic and international recipients; and (d) what are the CRA’s risk assessment tools, and the risk matrix surrounding charities with international intermediaries?

Q-2693² — May 3, 2024 — — With regard to the government response to Order Paper Question Q-2422 regarding the awarding of non-competitive contracts, for Export Development Canada and for Public Services and Procurement Canada, broken down by year, from 2016 to the present: for each contract, what is the (i) recipient’s total amount of the contract, (ii) reason, if any, for awarding the contract, (iii) name of the organization that received the contract?

Q-2694² — May 3, 2024 — — With regard to spending on consultants by the government, broken down by year since 2018, and by department or agency: what was the total spending on external consultants (professional and special services) that are not an employee of a Crown corporation, agent of the Crown, or another department of the Government of Canada?

Q-2695² — May 6, 2024 — — With regard to individuals who were made to repay or whose COVID-era benefits such as the Canada Emergency Response Benefit, the Canada Emergency Student Benefit, the Canada Recovery Benefit, the Canada Recovery Caregiving Benefit, the Canada Recovery Sickness Benefit or the Canada Worker Lockdown Benefit were clawed back by the Canada Revenue Agency: (a) how many of these individuals, broken down by province and territory, and by income level, were (i) the only parent of a one-parent family, (ii) Indigenous, broken down by First Nations people, status and non-status, Metis and Inuit, (iii) people living below the poverty line, (iv) people on disability, (v) individuals aged 65 or older; (b) how much money was repaid or clawed back, broken down by individuals who were (i) the only parent of a one-parent family, (ii) Indigenous, broken down by First Nations people, status and non-status, Metis and Inuit, (iii) people living below the poverty line, (iv) people on disability, (v) aged 65 or older; and (c) what is the total number of Canadians and the total amount which was repaid or clawed back?

Q-2696² — May 6, 2024 — — With regard to the government’s military spending since 2015: what are the annual amounts of investments and purchases of goods and services, broken down by province and territory?

Q-2697² — May 6, 2024 — — With regard to defence procurement contracts since 2015: what have been the industrial and technological benefits, broken down by province and territory?

Q-2698² — May 6, 2024 — — With regard to federal funding and loans to Canada’s grocery sector, since January 1, 2006: how much federal funding has been provided to Loblaw Companies Limited and its subsidiaries, (i) No Frills, (ii) Real Canadian Superstore, (iii) Shoppers Drug Mart, (iv) Pharmaprix, (v) Provigo, (vi) Atlantic Superstore, (vii) Independent, (viii) T&T, broken down by company, year and type of funding?

Q-2699² — May 6, 2024 — — With regard to the introduction of the new icon launched on May 3, 2024, by the Canadian Army: (a) when did the planning of this new icon begin; (b) how long did it take to design this icon; (c) what are the details of all contracts related to the design of the icon, including (i) what outside contractors were involved, (ii) how much each contractor was paid, (iii) whether any related contracts were sole sourced, and, if so, which ones, (iv) how long the contractor took to complete this work, (v) when this work was completed; (d) how much did it cost overall to design this icon; (e) how many staff, if any, were involved in the design of this icon; (f) which members of the Department of National Defence were involved in the approval of this icon; (g) who gave the final approval to utilize this icon; (h) what costs, if any, were associated with the promotion of this icon once the work was completed, in total and broken down by type of cost; (i) what are the costs (i) incurred to date, (ii) projected to be incurred, to initiate the use of the new icon, including, but not limited to, the placement on advertisements, uniforms, stationary, broken down by category; (j) who approved the (i) communications plan, (ii) tweets, related to the release of the new icon; (k) what are the details of all contracts related to communicating the launch of this icon, including (i) what outside contractors were involved, (ii) how much each of these contractors were paid, (iii) whether any related contracts were sole-sourced, and, if so, which ones, (iv) how long it took them to complete this work, (v) when this work was completed; (l) what are the details of all contracts signed related to the promotion of this icon, including (i) what outside contractors were involved, (ii) how much each of these contractors has been, or will be paid, (iii) whether any related contracts were sole-sourced, and, if so, which ones, (iv) how long it took them to complete this work, (v) when this work was completed, (vi) whether any advertising was purchased, and, if so, how much and on which platforms; (m) what are the details of all contracts related to the surveys, focus testing, public opinion testing, or any other research about the new icon, including (i) what outside contractors were involved, (ii) how much each of these contractors were paid, (iii) whether any related contracts were sole-sourced, and, if so, which ones, (iv) how long it took them to complete this work, (v) when this work was completed; (n) how many staff, if any, were involved in the surveys, focus testing, public opinion testing, or any other research about the new icon; and (o) for each focus group or public opinion research that was conducted, (i) what questions were asked, (ii) what topics were analyzed, (iii) what were the results?

Q-2700² — May 9, 2024 — — With regard to the approval rate for French-speaking international students: how many study permit applications, other than extension applications, did Immigration, Refugees and Citizenship Canada process in (i) 2023, (ii) 2024 to date, in total and broken down by country of residence?

Q-2701² — May 9, 2024 — — With regard to government hospitality expenditures related to the government’s supply and confidence agreement with the NDP, including any expenses related to all meetings, negotiations, or other events attended by those involved in the agreement: what are the details of such expenditures since the beginning of the 44th Parliament, including, for each, the (i) date, (ii) location, (iii) vendor, (iv) event description, (v) amount, (vi) number of attendees, (vii) names of the attendees?

Q-2702² — May 9, 2024 — — With regard to federal housing investments in the territories, since February 1, 2006, broken down by city and year: how much federal funding was provided to support the construction of (i) non-profit or community housing, (ii) cooperative housing, (iii) purpose-built rental housing, and how many units were developed?

Q-2703² — May 9, 2024 — — With regard to requests submitted through Jordan’s Principle and the Inuit Child First Initiative, broken down by fiscal year since the program's inception: (a) what is the total number of requests received from (i) parents or guardians of Indigenous children, (ii) Indigenous children at the age of consent in their province or territory, (iii) an individual authorized to represent an Indigenous child, parent, or guardian, (iv) businesses where the requester has authorized the business to represent them; (b) what is the total amount of funding requested through these programs by (i) 511825 Ontario Inc., (ii) Maryhomes Inc., (iii) Enterphase Child & Family Services, (iv) Hatts Off Inc., (v) Unison Treatment Homes for Youth Inc., (vi) Kom’s Kid Kare Agency, (vii) Kushions Inc., (viii) Hand in Hand Children’s Services; and (c) what measures does the government have in place to ensure that funding applied for by for-profit corporations is delivered in full to the children who need care?

Q-2704² — May 9, 2024 — — With regard to the Greenland Halibut in Nunavut, since 2017: (a) what are the details of all assessments of Greenland Halibut stocks, including the (i) date, (ii) location, (iii) conclusions; (b) what are the details of all Greenland Halibut fisheries management decisions, including the (i) date, (ii) scientific assessment used to justify the decision, (iii) decision on total allowable catch and sharing arrangements; (c) what investments has the government made to improve data collection on Greenland Halibut to make more informed decisions on Greenland Halibut fisheries; and (d) what efforts has the government made to incorporate Inuit traditional knowledge and Inuit science in Greenland Halibut data collection and fisheries decisions?

Q-2705² — May 16, 2024 — — With regard to members of the Border Services (FB) group who work at the Canada Border Services Agency and the commitment made by the Treasury Board of Canada Secretariat during the 2021 round of bargaining to resubmit the Border Services (FB) group’s proposal to introduce legislative amendments providing enhanced early retirement benefits under the public service pension plan, to facilitate an expedited opportunity to bring forward its related business case to the Public Service Pension Advisory Committee (PSPAC), and to facilitate a streamlined process to have these issues reviewed and ensure that related recommendations are brought forward in a timely manner: (a) who has the government consulted with through this process, including, but not limited to, members of the Border Services (FB) group, through their bargaining agent; (b) what information, advice, and recommendations have the (i) PSPAC, (ii) Public Service Alliance of Canada (PSAC), (iii) Public Sector Pension Investment Board (PSPIB), presented to the Treasury Board; (c) what information, statements, advice, and recommendations has the Treasury Board presented to the (i) PSPAC, (ii) PSAC, (iii) PSPIB; (d) what is the timeline to implement the promised changes; and (e) what steps still need to be taken to ensure these changes take place?

Q-2706² — May 16, 2024 — — With regard to the electoral district of Port Moody—Coquitlam, broken down by fiscal year since 2021-22: what are the details of all federal transit infrastructure investments, including direct transfers to municipalities, regional district associations or First Nations, national parks, etc.?

Q-2707² — May 16, 2024 — — With regard to all federal funding committed to the creation and maintenance of housing stock in the federal electoral district of Port Moody—Coquitlam, broken down by fiscal year since 2021-22: (a) what is the total amount committed, broken down by funding stream; (b) what was the total amount spent; (c) how much new housing stock was created; and (d) of the housing stock in (c), how much is (i) purpose-built rental housing, (ii) non-profit or community housing, (iii) cooperative housing, (iv) affordable housing for seniors?

Q-2708² — May 16, 2024 — — With regard to consultations undertaken by the government on the Canada Disability Benefit, held between November 15, 2023, and January 4, 2024: (a) what are the details of all such consultations, including the (i) date of the consultation, (ii) organizations that were consulted, (iii) recommendations that were made; (b) what are the details of all opportunities for public consultation, including (i) online engagement, (ii) in-person consultation; and (c) what are the details of all reports, discussion documents, or documents including recommendations for the Canada Disability Benefit, including the (i) title of the document, (ii) identifying number, (iii) date of the document, (iv) recommendations within the document?

Q-2709² — May 16, 2024 — — With regard to all federal grants and loans given to Starlight Investments, since January 1, 2006: (a) how much federal funding has been provided, broken down by (i) province and territory, (ii) fiscal year, (iii) funding type; and (b) how many housing units have been built as a result of the funding, broken down by (i) purpose-built rental housing, (ii) cooperative housing, (iii) non-profit or community housing?

Q-2710^1-2 — May 21, 2024 — — With regard to the Security Infrastructure Program (SIP) and the Expanded Security Infrastructure Program (ESIP), broken down by program, fiscal year and province or territory, since 2015-16: (a) how many applications were (i) received, (ii) funded, (iii) denied funding; (b) which projects were denied funding broken down by the reason they were denied; and (c) for each of the 600 approved projects under SIP, and the 173 approved projects under ESIP, (i) under what stream was the project approved (regular SIP, ESIP or the Severe Hate-Motivated, Incident stream), (ii) what was the total cost approved for the project, (iii) what was the total amount of federal funding delivered, (iv) what protection measures were funded by the project, (v) which eligible recipient classes did the project qualify under, (vi) if the recipient was a place of worship, what was the listed spiritual or religious belief that the organization identified in the application, (vii) what were the demographic groups identified as primarily benefiting from the project?

Q-2711² — May 21, 2024 — — With regard to government procurement from entities currently banned from receiving investment in the United States by executive order due to posing security threats: (a) has any department, agency, Crown corporation or other government entity, purchased any materials, goods, software or services from the following entities, (i) China Head Aerospace Technology Co., (ii) China Telecommunications Corporation, (iii) Hangzhou Hikvision Digital Technology Co. Ltd., (iv) Huawei Technologies Co. Ltd., (v) ZTE Co. Ltd., since 2016; (b) if the answer for any of the entities listed in (a) is affirmative, what are the details of all such purchases on contract, including, for each, the (i) name of the department, agency, Crown corporation or other government entity that made the purchase, (ii) date, (iii) vendor, (iv) value or amount, (v) description of the goods or services, including the quantity of each, if applicable, (vi) manner in which the contract was awarded (sole-sourced, competitive bid), (vii) start and end dates, if applicable; and (c) what measures or policies are in place to ensure that purchases from these entities do not compromise Canada's national security and align with international commitments and sanctions?

Q-2712² — May 21, 2024 — — With regard to the statement from the Minister of Health on March 20, 2024, indicating that Health Canada is pursuing legislative and regulatory mechanisms to place restrictions on the flavors of nicotine replacement therapies: (a) what specific studies have been conducted by Health Canada related to the impact of such a restriction; and (b) what are the details of all studies in (a), including, for each, the (i) date the study was completed, (ii) names and titles of who conducted the study, (iii) methodology, (iv) findings, (v) website location where the study can be found online?

Q-2713² — May 21, 2024 — — With regard to government support for Eastern Canada ferry services and the Wood Islands-Caribou route: (a) what is the total cost to date for the design and construction of the new ferry; (b) what are the details of all contracts over $1,000 entered into by the government related to the new ferry since November 4, 2015, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the goods or services provided; (c) what is the launch date for the new vessel; (d) how far behind schedule is the design and production of the new vessel; (e) since November 4, 2015, what has been the total cost for maintenance and repair of the MV Holiday Island and MV Confederation vessels; (f) of the vessels in (e), how many hours of downtime did each vessel have during the season; (g) how many crossings were lost due to vessel downtime; (h) what is the total loss of revenue due to vessel downtime; and (i) what is the total cost to secure interim ferries for the route, including the (i) purchase, (ii) lease, (iii) rental, (iv) maintenance, (v) repairs, (vi) retrofit?

Q-2714² — May 21, 2024 — — With regard to federal Crown land which has been sold or donated for the purpose of building housing since January 1, 2016: (a) what are the details of all such transactions, including, for each, the (i) date, (ii) size of the land involved, (iii) sale price, if applicable, (iv) entity the land was sold or transferred to, (v) location, (vi) number of houses or units expected to be built on the land, (vii) number of houses or units built on the land to date, if known; and (b) what was the total square area of land transferred in (a), broken down by year?

Q-2715² — May 21, 2024 — — With regard to Temporary Resident Permits (TRP), broken down by year for each of the last five years: (a) how many TRPs have been issued in total and broken down by those who applied (i) abroad prior to arriving in Canada, (ii) at a point of entry, (iii) while already in Canada; (b) for each part of (a), how many and what percentage of the applications required a police certificate or a criminal records check; (c) of the applications in (b), how many (i) did not include a police certificate or criminal records check, (ii) included documents which showed crimes that were severe enough to deny the TRP application; (d) how many individuals were given a TRP despite not submitting a police certificate or passing a criminal records check; and (e) what is the breakdown of (a) through (d) by country of origin?

Q-2716² — May 22, 2024 — — With regard to Immigration, Refugees and Citizenship Canada (IRCC), as of March 31, 2024: (a) how many employees or full-time equivalents (FTEs) are currently employed by IRCC; (b) how many of these employees or FTEs are classified as EX or above; (c) how many of these employees or FTEs are classified below the EX level; (d) of the employees or FTEs that are classified as EX or above and below EX, how many work (i) physically full-time in a government office, (ii) completely remotely, (iii) in a hybrid situation, where they work certain days in the office and certain days remotely; (e) for hybrid workers, how many days per week are they required to come to an office location; (f) what monitoring is done by IRCC to ensure that remote and hybrid employees are putting in the equivalent to a full day while working remotely; (g) what remedial action is undertaken when a supervisor has discovered that an employee is not putting in the equivalent to a full day while working remotely, and what thresholds or limits have been established by IRCC before formal action is taken, such as loss of pay or termination; (h) how many instances of remedial and formal action were taken in the 2023-24 fiscal year; and (i) if remedial or formal action is not taken when the situation outlined in (g) occurs, why not?

Q-2717² — May 22, 2024 — — With regard to the Department of National Defence and NORAD modernization: (a) how much of the $38.6 billion announced for the modernization has been spent to date, in total, and broken down by project; (b) of the 20 project timelines announced in June 2022, which ones are (i) on track for the completion of the definition phase or to be finished within the stated time, (ii) delayed; and (c) for each project which is delayed, (i) what is the new projected completion date, (ii) what is the reason for the delay?

Q-2718² — May 22, 2024 — — With regard to the RCMP's Canadian Firearms Program in British Columbia (BC): (a) how many full-time individuals are currently employed by the program in BC; (b) how many staff members in BC work exclusively remote or from home; (c) how many BC staff members work exclusively in person; (d) what percentage of all BC work hours are spent (i) in person, (ii) remotely or at home; and (e) what is the (i) average salary, (ii) total annual expenditures on salaries, for BC employees of the Canadian Firearms Program?

Q-2719² — May 22, 2024 — — With regard to the Canadian High Arctic Research Station (CHARS): (a) how many employees or full-time equivalents were employed at CHARS during the last 12 months; (b) how many foreign nationals have worked or researched at CHARS, broken down by year and country of origin for each of the last eight years; (c) which countries are currently allowed to send individuals to work at CHARS; and (d) what are the pre-screening security requirements for individuals to work at CHARS?

Q-2720² — May 22, 2024 — — With regard to the action taken by the government to recognize Machias Seal Island as a part of Canada: (a) what specific actions, if any, have been taken to recognize the island as a part of Canada, broken down by each department and agency; and (b) on what date did each action in (a) take place?

Q-2721² — May 22, 2024 — — With regard to costs incurred by the government related to court cases and hearings associated with the deportation order or former deportation order of Muhammad Zain UI Haq: what are the costs incurred to date, including any legal costs as well as costs related to administering the hearings or court cases, in total and broken down by type of cost and action related to the expense (federal appeal, lower court, etc.)?

Q-2722² — May 22, 2024 — — With regard to Immigration, Refugees and Citizenship Canada (IRCC) housing refugees in hotels, motels, dorms, or similar types of facilities in Alberta: (a) how many have been housed, broken down by year for the last two fiscal years; (b) what is the total number of refugees housed, per month, broken down by year for the last two fiscal years; (c) which hotels are being used; (d) how many hotel rooms were (i) paid for by IRCC, (ii) occupied; (e) what is the capacity of each hotel that is being occupied by refugees; (f) how many refugees are staying in each hotel; (g) what is the average length of time IRCC expects (i) an individual refugee, (ii) a refugee family, to be housed in a hotel room; (h) what is the average length of time that a refugee has been housed, funded by the government, in a hotel; (i) what is the average cost of such housing per night for each refugee; (j) what was the total cost IRCC paid hoteliers to house refugees on May 1, 2024; (k) what is the average hotel cost per refugee for daily meals and refreshments; (I) what was the total cost paid to hoteliers to feed refugees; (m) what are the countries of origin for the refugees housed; (n) what is the breakdown of refugees accommodated in Alberta by each country of origin; (o) how much federal funding was transferred to each municipality with federally-funded refugee reception centres (Edmonton, Calgary, Lethbridge, Medicine Hat, Red Deer); (p) how much federal funding has been transferred to Alberta for the purpose of dealing with the influx of refugees in the province; (q) how much federal funding was transferred to local not-for-profit, charitable, and nongovernmental organizations in Alberta to deal with the influx of refugees in the cities of (i) Calgary, (ii) Edmonton, (iii) Red Deer, (iv) Medicine Hat, (v) Lethbridge, since 2022; (r) what are the names of the organizations in (q) and how much did each organization receive; (s) how many more refugees does IRCC currently project will require hotel accommodation in Alberta; (t) how many refugees have moved out of government-funded hotel rooms in Alberta and into personal accommodations; and (u) what is the summary of the terms and conditions of the financial agreement that IRCC has with hotels located in Alberta that house refugees and receive federal funding to provide this service, broken down by hotel, including the name of each hotel?

Q-2723² — May 22, 2024 — — With regard to the policy on pathways to permanent residency for Hong Kong residents (hereinafter the policy), which falls under humanitarian and compassionate considerations: (a) how many applicants under the policy were approved in 2023, broken down by month; (b) how many applicants under the policy have been approved since the beginning of 2024, broken down by month; (c) what is the policy’s specific admission target; and (d) what is the policy’s maximum admission target limit for humanitarian and compassionate considerations?

Q-2724² — May 23, 2024 — — With regard to the residence located in Winnipeg previously known as Lions Place: (a) did the City of Winnipeg or the Government of Manitoba contact the federal government to request assistance in maintaining non-profit ownership of Lions Place; (b) what measures did the federal government undertake to assist, prevent or otherwise shape the sale of Lions Place to its purchaser, Mainstreet Equity; (c) what financing or support did the Canada Mortgage and Housing Corporation (CMHC) provide to the previous owner of Lions Place, Lions Housing Centres Inc., prior to its sale to Mainstreet Equity, broken down by year and dollar amount; (d) what financing or support did the CMHC provide to Mainstreet Equity to assist with its purchase of Lions Place, broken down by year and dollar amount; (e) did any CMHC board members recuse themselves from participating in votes or decisions surrounding the sale of Lions Place; and (f) since January 1, 2015, has any CMHC board member recused themselves from decisions surrounding the sale or purchase of a residential property?

Q-2725² — May 23, 2024 — — With regard to loans disbursed through the Canada Student Financial Assistance Program, from 2015 to present, broken down by debtors’ racial or ethnic background, gender, and immigration or citizenship status: (a) what is the average total outstanding loan balance; (b) what is the average outstanding loan balance of debtors who completed a graduate degree; (c) what is the average outstanding loan balance owed among debtors who completed a bachelor’s degree; (d) what is the average outstanding loan balance owed by debtors who completed a college or polytechnic diploma; (e) what percentage of student debtors have missed at least one payment of their scheduled repayment plan; (f) what percentage of student debtors have missed at least (i) three months, (ii) six months, of scheduled payments; (g) what percentage of student loans have fallen into a default position; and (h) what is the average time taken by student debtors to repay their loan in full?

Q-2726² — May 24, 2024 — — With regard to the testimony from the Information Commissioner on May 16, 2024, at the Standing Committee on Access to Information, Privacy and Ethics in which she said that "We are now looking at a total funding shortfall of $700,000 which represents a reduction in my budget of approximately 5%": why did the government make this reduction to the Information Commissioner's budget?

Q-2727² — May 24, 2024 — — With regard to the Aboriginal Entrepreneurship Program: (a) what is the number of businesses which have applied, as of May 23, 2024, broken down by province or territory, to the (i) Access to Business Opportunities stream, (ii) Access to Capital stream; (b) what is the total number of businesses which have received funding or assistance, broken down by province or territory, through the (i) Access to Business Opportunities stream, (ii) Access to Capital stream; (c) what is the total funding, in dollars, distributed to the (i) Access to Business Opportunities stream, (ii) Access to Capital stream, for the fiscal years 2020-21, 2021-22 and 2022-23; (d) what is the average funding amount provided to each approved applicant, broken down by province or territory, through the (i) Access to Business Opportunities stream, (ii) Access to Capital stream; (e) how does the government quantify the program's level of success; and (f) does the government have any evidence or statistics which demonstrate that the (i) Access to Business Opportunities increased Indigenous business opportunities, (ii) Access to Capital allowed Indigenous businesses to expand, and, if so, what are they?

Q-2728² — May 24, 2024 — — With regard to the Firearms Act, the Firearms Buyback Program (hereinafter the program) and the firearms ban announced by the government on May 1, 2020: (a) what is the projected cost of the program and the firearms ban combined; (b) what is the projected launch date for the program; (c) what method will be used to confiscate firearms not voluntarily turned in once the amnesty period accompanying the firearms ban expires; (d) which agencies, departments and personnel will be called on to execute the program; (e) how many firearms were stolen from departments, agencies and personnel, broken down by year, since January 1, 2016; (f) of the firearms in (e), how many have been recovered; (g) are there short-term plans to require federal law enforcement personnel to (i) follow the same storage and transportation laws as licensed firearm owners or be charged with an offence under the Firearms Act for negligent storage and handling of a firearm if they do not, (ii) obtain a restricted possession and acquisition license prior to being issued a firearm; (h) how does the government expect the program and the ban to affect the number of annual violent firearm incidents; (i) when confiscating firearms from licensed owners, what solution will be offered when the value of the confiscated firearms substantially exceeds the proposed compensation amount that is outlined in the program; (j) is the program alone enough to substantially reduce the annual rate of violent firearm crimes that are committed; (k) what proof does the government have that the firearms banned by Order-in-Council SOR2020-96 are statistically more likely to be used in incidents of violent crime; and (I) why was the aforementioned firearms ban not done through an Act of Parliament instead of an Order-In-Council?

Q-2729² — May 24, 2024 — — With regard to the Veteran Homelessness Program: (a) how much funding was allocated to the program in federal budgets, in total and broken down by which federal budget the funding was allocated in; (b) how much funding (i) has been allocated to date, (ii) will be allocated to each of the two funding streams; (c) how much has the government spent to date on the program, in total and broken down by the type of expenditure; and (d) how much is the government projected to spend on the program in each of the next five years?

Q-2730² — May 24, 2024 — — With regard to government dealings with the Toronto Atmospheric Fund (TAF) and those representing the fund, broken down by year since 2016 and by department or agency: (a) how much funding, including any funding provided through contracts, has been provided to the TAF, in total and broken down by initiative or type of funding; and (b) what are the details of any reports received from the TAF, including, for each, the (i) date, (ii) author or entity that wrote the report, (iii) title, (iv) organizations, companies, or entities represented by the author, (v) amount of funding provided in relation to the report, both directly and indirectly?

Q-2731² — May 27, 2024 — — With regard to the Northern Abandoned Mine Reclamation Program: (a) how much money has been spent on the program to date, in total, and broken down by year and by site; (b) what specific work has been done at each site; (c) what is the detailed timeline for what work will take place each year between now and the completion of each reclamation project; (d) what are the details of each contract over $50,000 signed by the government related to the program, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the goods and services, (v) details of how the contract was awarded (sole-sourced, competitive bid); (e) have any of the liabilities, of each mine site, changed since 2019, and, if so, what (i) was the original liability, (ii) is the current liability, (iii) was the reason for the change in liability; and (f) if changes in liability occurred, in each case, what efforts were made by the government to mitigate these liabilities?

Q-2732² — May 27, 2024 — — With regard to counterfeit goods discovered and seized by the Canada Border Services Agency (CBSA), since January 1, 2020, and broken down by year: (a) what is the value of the goods discovered, in total, and broken down by year and by month; (b) for each seizure, what was the (i) date, (ii) quantity, (iii) estimated value, (iv) location or port of entry where the goods were discovered, (v) product description, (vi) country of origin; and (c) what is the estimated percentage of counterfeit goods which are intercepted by the CBSA versus those which are smuggled into Canada without being intercepted?

Q-2733² — May 27, 2024 — — With regard to government measures to stop counterfeit goods from being sold in Canada: (a) what are the details of the specific measures the government has taken since 2016 to stop the sale of counterfeit goods in Canada; (b) how many individuals has the RCMP arrested for trafficking or attempting to sell counterfeit goods, broken down by year, since 2016; (c) what are the descriptions of all counterfeit items that were seized in relation to the arrests in (b), broken down by year; (d) what is the government’s estimate on the value of the counterfeit goods sold each year in Canada, in total, and broken down by type of merchandise; (e) does the government have any policy prohibiting government employees from selling such products, and, if so, what is it; and (f) does the government have any policy which would prevent employees, or any other individuals who have been issued a government phone or mobile device, from using that device to sell counterfeit products, and, if so, what is it?

Q-2734² — May 27, 2024 — — With regard to travel expenses incurred by the government for travel by a minister’s exempt staff member, that was not disclosed through proactive disclosure, since January 1, 2016: (a) what are the details of all such expenses, including the (i) title of the traveller, (ii) origin, (iii) destination, (iv) date, (v) total expenditures, broken down by type (airfare, accommodation, etc.); (b) why was the expenditure not reported through proactive disclosure; and (c) do any exempt staff members of ministers have certain travel expenses, such as trips home to see family, included as part of their employment agreement or contract, and, if so, how many staff members have this benefit?

Q-2735² — May 28, 2024 — — With regard to the backlog in processing asylum claims: (a) how many claims are currently waiting to be processed; (b) what is the breakdown of (a) by the claimant’s country of origin; (c) what is the breakdown of (a) by how long it has been since the asylum claim was first made (less than a year, one to three years, over three years, etc.); and (d) what are the government’s goals, including a detailed timeline of when the backlog will be (i) reduced, (ii) eliminated?

Q-2736² — May 28, 2024 — — With regard to Immigration, Refugees and Citizenship Canada's Humanitarian and Compassionate immigration category, in 2023: (a) what is the total amount of applications under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (b) what is the total number of individual names and the total number of applications under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (c) what is the total amount of applications of Ukrainian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (d) what is the total number of individual names and the total number of applications of Ukrainian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (e) what is the total amount of applications of Haitian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (f) what is the total number of individual names and the total number of applications of Haitian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (g) what is the total amount of applications of Sudanese origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (h) what is the total number of individual names and the total number of applications of Sudanese origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (i) what is the total amount of applications of Hong Kongese origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (j) what is the total number of individual names and the total number of applications of Hong Kongese origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (k) what is the total amount of applications of Colombian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (I) what is the total number of individual names and the total number of applications of Colombian origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; (m) what is the total amount of applications of Venezuelan origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed; and (n) what is the total number of individual names and the total number of applications of Venezuelan origin under this category that (i) have been submitted, (ii) have been accepted, (iii) have been rejected, (iv) have been withdrawn, (v) are still waiting to be processed?

Q-2737² — May 28, 2024 — — With regard to the government’s efforts to recover funds from government contract recipients for any reason, including overpayment, failure to meet contractual obligations or any other reason, broken down by department or agency: what are the details of all such efforts which have taken place since January 1, 2022, including, for each, the (i) date of the contract, (ii) contract value, (iii) vendor, (iv) description of the products or services, (v) amount paid out, (vi) recovery amount sought by the government, (vii) amount recovered to date, (viii) reason for the recovery, (ix) date on which recovery efforts began?

Q-2738² — May 28, 2024 — — With regard to government expenditures on other professional services not elsewhere specified (Treasury Board code 0499 or similar), during the 2023-24 fiscal year: (a) what was the total amount spent on such services, broken down by each department, agency, or other government entity; and (b) what are the details of each expenditure, including the (i) date, (ii) vendor, (iii) amount, (iv) description of the services, (v) details of how the contract was awarded (sole-sourced or competitive bid)?

Q-2739² — May 28, 2024 — — With regard to Possession and Acquisition Licenses (PAL) and Restricted Possession and Acquisition Licenses (RPAL) applications for renewal or first licensing, as of December 31, for each year from 2016 to 2023, inclusively, broken down by type of application (New PAL, Renewal, Minor PAL, or Transfer), and province or territory of application: (a) how many applications have been in processing for over (i) one month, (ii) three months, (iii) six months, (iv) one year, (v) 18 months; (b) how many of the applications required secondary and tertiary reviews; (c) how many applications were delayed due to administrative issues; (d) how many employees or full time equivalents were employed at the Canadian Firearms Program office to process applications; and (e) how many PAL or RPAL renewal applications remained in processing six months after the listed expiry date on the license?

Q-2740² — May 28, 2024 — — With regard to the Canada Emergency Business Account (CEBA) Call Centre, since it was established and until May 2024, inclusively, broken down by month and by province or territory of call origin: (a) how many phone calls were received by the centre; (b) how many calls went unanswered; and (c) how many employees or full-time equivalents were employed to answer calls at the centre?

Q-2741² — May 29, 2024 — — With regard to Statistics Canada’s (StatCan) released data regarding "provisional deaths and excess mortality in Canada" which reported "significant excess mortality starting in January 2022" especially “among individuals younger than 45” and the Privy Council Office’s (PCO) use of “Winning Communication Strategies” to “not shake public confidence” (ATIP, May 2021): (a) why did StatCan wait until September 2022 to publish excess mortality data amongst young Canadians when the data was available around March or April 2022; (b) who signed off on the data in (a); (c) what steps were taken to investigate the underlying reasons for this unusual finding of excess deaths in young persons; (d) who or what agency or entity informed the Office of the Prime Minister and the Cabinet about this finding; (e) how and when were these statistics communicated to provincial and territorial health ministers, regulatory health care colleges, chief medical officers and coroner's offices, in order to provide Canadians with updated data to facilitate informed consent; (f) which officials at which agency or entity hosted press releases regarding this unusual rise in deaths among those Canadians under the age of 45 years; (g) as per the Public Health Agency of Canada’s ‘Cases Following Vaccination’ reports from June 10, 2022 to September 23, 2022, what was the number of “COVID-19 Cases Deceased” for each week as of the week which ended on June 12, 2022 until the week which ended on August 28, 2022, broken down by the vaccine status of the individual, including those having received (i) no dose, (ii) a single vaccine dose, (iii) the primary program of two doses, (iv) one additional dose, (v) two additional doses; (h) according to the numbers in (f), which group had the largest number of “Cases deceased” each week; (i) specifically with respect to the unvaccinated group and the two additional doses group, during those weeks, which of these two groups demonstrated fewer COVID-19 outbreaks; (j) were there any press releases communicating the findings in (i) to the public; (k) what are the details of the memo drafted by the PCO in May 2021, that instructed recipients to skew statistics to minimize the impact of vaccine-related deaths or injuries, including (i) which agencies or entities and which specific officials received this memo, (ii) how did the agencies or entities carry out the PCO’s instructions vis-a-vis statistical skewing, (iii) who at each agency or entity signed off on the report of the data; and (l) why is there a discrepancy between the data that was released on the StatCan website for “other ill-defined and unspecified causes of mortality” from 2020 to 2022, a reported 16,043 deaths, and the value provided in the government response to Order Paper Question Q-1115, of 55,975 deaths for the same year and same category?

Q-2742² — May 29, 2024 — — With regard to the High Frequency Rail project and the options analyzed by CPCS Transcom Limited (CPCS) and WSP Global Inc. (WSP), to enhance passenger rail service in Southwestern Ontario: (a) on what date was the analysis provided to the Minister of Transport; (b) what are the details of the findings of the analysis; (c) on what date will the findings be made available on the government’s website; and (d) how much did the government pay CPCS and WSP for these analyses?

Q-2743² — May 29, 2024 — — With regard to the participation of Global Affairs Canada, Canadian Heritage, Telefilm Canada, and the National Film Board of Canada at events, including South by Southwest (SXSW) Austin, SXSW Australia, Berlinale, the Academy Awards, and the Cannes Film Festival, since January 1, 2023, and broken down by each event: (a) what travel expenses were incurred by employees in attendance or in support of these events, in total and broken down by (i) accommodation, (ii) airfare, (iii) other transportation, (iv) meals or per diems, (v) other travel expenses, broken down by type; (b) what was the total amount spent on hospitality at each event; (c) what are the details of all hospitality expenditures, including, for each, the (i) event name, (ii) location, (iii) vendor, (iv) amount, (v) event description, (vi) number of attendees; (d) how many employees travelled to or attended each event; (e) how much was spent on tickets for each primary event; (f) how much was spent on tickets for each secondary event, such as an afterparty, including the name of each event; (g) what are the details of all contracts signed related to any of these events, including, for each, the (i) date, (ii) vendor, (iii) location, (iv) amount, (v) description of the goods or services, (vi) manner in which the contract was awarded (sole-sourced or competitive bid); (h) what economic returns were directly attributed to these government entities participating in these events, including the (i) Key Performance Indicators used to gauge the success of each, (ii) details of any contracts obtained as a result of participating in each event; and (i) what are the future plans for involvement or attendance at these events and any projected expenditures related to these plans?

Q-2744² — May 29, 2024 — — With regard to Canada’s Heads of Mission to each G7 member state, since January 1, 2022, and broken down by year: (a) how much has been spent on lobbyists and consultants, in total and broken down by embassy or high commission; (b) what is the breakdown of (a) by type of service (lobbying or consulting); and (c) what are the details of each contract for lobbying or consulting for any embassy or high commission in a G7 country abroad, including, for each, the (i) date, (ii) vendor, (iii) amount, (iv) description of the services, (v) manner in which the contract was awarded (sole-sourced or competitive bid)?

Q-2745² — May 29, 2024 — — With regard to the procurement, review and contents of the contract for the Pfizer COVID-19 mRNA vaccine signed by the former Minister of Public Services and Procurement in 2020: (a) when did the former Minister of Public Services and Procurement, the former Minister of Health and Health Canada initially receive the Pfizer contract; (b) which entities and agencies reviewed the contents of the Pfizer contract and who performed the review in each entity and agency; (c) which entities and agencies approved the final terms of the Pfizer contract and who signed the approval in each entity and agency; (d) did the contract specify whether their product was serialized by the manufacturer; (e) what is the purpose of product serialization by any drug manufacturer; (f) if the answer to (d) is negative, why not; (g) did the Pfizer contract provide unequivocal confirmation that their product was studied for its (i) efficacy to prevent infection of SARS-CoV-2, (ii) efficacy to prevent serious illness, (iii) efficacy to prevent hospitalization, (iv) efficacy to prevent death, (v) long-term side effects, (vi) ability to stop transmission of SARS-CoV-2, (vii) known adverse effects; (h) did the contract state that the mRNA vaccine was tested for its ability to stop transmission of SARS-CoV-2 to others; (i) with respect to the responses to (g) and (h), when was (i) Dr. Howard Njoo, (ii) Dr. Theresa Tam, (iii) Dr. Supriya Sharma, (iv) Dr. Caroline Quach-Thanh, (v) the Prime Minister, (vi) the Deputy Prime Minister and Minister of Finance, (vii) the former Minister of Health, (viii) the former Minister of Transport, provided this information; (j) with respect to the responses to (g)(i) to (g)(vii), when was the Office of the Prime Minister informed about the limitations of the vaccine as listed in the Pfizer contract and who informed them; and (k) who approved the communications plan after the contract was received and analyzed in early 2021 that would inform Canadians that the Pfizer product was "safe and effective" and prevented transmission of SARS-CoV-2 to others?

Q-2746² — May 29, 2024 — — With regard to federal funding in the constituency of Winnipeg Centre, between November of 2019 and May of 2024: (a) what applications for funding have been received, including, for each, (i) the name of the organization, (ii) the department, (iii) the program and sub-program under which they applied for funding, (iv) the date of the application, (v) the amount applied for, (vi) whether funding has been approved or not, (vii) the total amount of funding, if funding was approved; (b) what funds, grants, loans, and loan guarantees has the government issued through its various departments and agencies in this constituency that did not require a direct application from the applicant, including, for each, the (i) name of the organization, (ii) department, (iii) program and sub-program under which they received funding, (iv) total amount of funding, if funding was approved; and (c) what projects have been funded in this constituency by organizations tasked with subgranting government funds (e.g. Community Foundations of Canada), including, for each, the (i) name of the organization, (ii) department, (iii) program and sub-program under which they received funding, (iv) total amount of funding, if funding was approved?

Q-2747² — May 30, 2024 — — With regard to Policy Horizons Canada and the May 2024 report entitled “The Disruptions on the Horizon”: (a) which individuals or organizations, outside of the Government of Canada, contributed to the report; (b) were any of the individuals or organizations in (a) paid to participate, and, if so, how much was each paid; (c) what kind of format was used to gather opinions from individuals or organizations; (d) what specific questions were posed to the individuals or organizations in (a); (e) did Policy Horizons Canada attempt to gather the opinions of individuals or organizations outside of those that participated, and, if so, what are the details, including (i) their names, (ii) the reason provided to Policy Horizons Canada for why these individuals or organizations chose not to participate; (f) what was the total cost to research, prepare and publish the report; (g) has a lessons-learned exercise been conducted following the release of the report, and, if so, what were the results; and (h) is there a follow-up report anticipated and, if so, what are the details, including (i) the estimated date of release, (ii) the proposed budget, (iii) the focus of that report, (iv) whether the same individuals and organizations be consulted, (v) whether the lessons learned from the current report be incorporated into the upcoming report?

Q-2748² — May 31, 2024 — — With regard to government projects announced since November 4, 2015, with an initial projected cost of over $5,000,000, that were completed within their original projected timeline and at or below the cost originally announced: (a) what are the details of all such projects, including, for each, the (i) location, (ii) project description, (iii) date of the first project announcement, (iv) cost originally announced, (v) originally announced completion date, (vi) actual project cost, (vii) actual completion date, (viii) website address where the original announcement or press release can be found; and (b) how many and what percentage of such projects were completed (i) on time, (ii) at or below the originally announced cost?

Q-2749² — May 31, 2024 — — With regard to government involvement, including the Canada Mortgage and Housing Corporation, in the creation of rental housing in Canada, including through both direct investments and bilateral agreements, between February 1, 2006, and November 4, 2015, broken down by program, province or territory, and by year for each part of the question: (a) how many new units were built as a result of federal funding; (b) how much funding was provided to support the construction of non-profit or community housing and how many units were built; (c) how much federal funding was provided to support the construction of cooperative housing and how many units were built; and (d) how much federal funding was provided to support the construction of purpose-built rental housing and how many units were built with that funding?

Q-2750² — May 31, 2024 — — With regard to Canada Mortgage and Housing Corporation's (CMHC) programs, CMHC's Affordable Housing Centre, and all other CMHC initiatives, between February 1, 2006, and October 1, 2015: (a) how many new units were developed as a result of CMHC funding; (b) how much funding was provided to support the construction of non-profit or community housing and how many units were developed; (c) how much CMHC funding was provided to support the construction of cooperative housing and how many units were developed; and (d) how much CMHC funding was provided to support the construction of purpose-built rental housing and how many units were developed?

Q-2751² — May 31, 2024 — — With regard to government involvement, including the Canada Mortgage and Housing Corporation, in the creation of rental housing in Canada, including through both direct investments and bilateral agreements, between February 1, 2006, and November 4, 2015, broken down by program, province or territory, and by year for each part of the question: (a) how many new units were developed as a result of federal funding; (b) how much funding was provided to support the construction of non-profit or community housing and how many units were developed; (c) how much federal funding was provided to support the construction of cooperative housing and how many units were developed; and (d) how much federal funding was provided to support the construction of purpose-built rental housing and how many units were developed with that funding?

Q-2752² — May 31, 2024 — — With regard to Canada Mortgage and Housing Corporation's (CMHC) programs, CMHC's Affordable Housing Centre, and all other CMHC initiatives, between February 1, 2006, and October 1, 2015: (a) how many new units were built as a result of CMHC funding; (b) how much funding was provided to support the construction of non-profit or community housing and how many units were built; (c) how much CMHC funding was provided to support the construction of cooperative housing and how many units were built; and (d) how much CMHC funding was provided to support the construction of purpose-built rental housing and how many units were built?

Q-2753² — June 3, 2024 — — With regard to visas for international students in Canada: how many international students (i) are currently studying in Canada, (ii) are studying at institutions accredited by Universities Canada, (iii) are studying at institutions that are members of the National Association of Career Colleges, (iv) have transferred institutions within Canada during their period of study, (v) are in a K-12 program?

Q-2754² — June 3, 2024 — — With regard to the Canada Housing Benefit, broken down by province or territory and fiscal year: (a) how many households received the benefit; (b) how many seniors aged 65 or older received the benefit; (c) how many people living with disabilities received the benefit; and (d) how many Indigenous peoples received the benefit, broken down by identity such as (i) Inuit, (ii) Métis, (iii) First Nation?

Q-2755² — June 3, 2024 — — With regard to temporary resident permits specific to victims of human trafficking, since November 4, 2015: (a) how many applications have been received; (b) how many permits have been issued; (c) how many permits were denied; (d) what is the breakdown of (a) to (c) by (i) year, (ii) month, (iii) gender, (iv) source country; (e) for permits in (b), what is the breakdown based on ministerial instructions 1(1), 1(2) and 2; and (f) what is the average wait time for an individual who applies for a temporary resident permit specific to victims of human trafficking?

Q-2756² — June 3, 2024 — — With regard to the government's Disaster Mitigation Adaptation Fund applications and the statements made by the Mayor of Merritt, Michael Goetz, and the Mayor of Princeton, Spencer Coyne, both in British Columbia, that their municipalities' applications for funding under this program were denied by the government without explanation: (a) why was Merritt’s application denied; (b) why was Princeton’s application denied; and (c) how do these funding rejections align with the Prime Minister’s statement to these communities after the flooding that he and his government would “have their backs”?

Q-2757² — June 3, 2024 — — With regard to Destination Canada: (a) how much economic activity is generated in Canada each summer from the domestic tourism industry; (b) of the economic activity in (a), how much and what percentage of (i) passengers, (ii) economic activity, is from domestic tourists who arrived via automobiles or road trips; and (c) what is Destination Canada's position on the statement regarding car trips that was made by the Minister of Health on May 30, 2024, that “They can enjoy their 10 hours in the car and let the planet burn”?

Q-2758² — June 3, 2024 — — With regard to the Climate Action Incentive Payment or the Canada Carbon Rebate, broken down by province or territory and by fiscal year, since the introduction of the carbon tax: (a) how many individual tax filers opted in to receive the rural supplement; and (b) how many individual tax filers were eligible to receive the rural supplement?

Q-2759² — June 3, 2024 — — With regard to government involvement, including the Canada Mortgage and Housing Corporation, in the creation of rental housing in Canada, including through both direct investments and bilateral agreements, between February 6, 2006, and November 4, 2015: how many new units were (i) built, (ii) developed, as a result of federal funding?

Q-2760² — June 3, 2024 — — With regard to the change announced by the Prime Minister on May 24, 2024, that Catherine Blewett, the Secretary of the Treasury Board, was being reassigned to become a Senior Official at the Privy Council Office (PCO): (a) what will her responsibilities be as a Senior Official at the PCO; (b) why was the Senior Official position not listed in the last organizational structure chart published by the PCO in April 2024; (c) where will the Senior Official position fit in to the PCO's organizational structure chart; and (d) how many days per week will she be required to show up in person at the PCO in Ottawa?

Q-2761² — June 3, 2024 — — With regard to Immigration and Refugee Board hearings on refugee claims, in 2023: (a) for accepted written hearings, (i) what is the total number of persons on all applications, (ii) what is the amount of applications that had one person's name attached, (iii) what is the amount of applications that had more than one person's name attached, (iv) what is the amount of applications that had a marital partner's name attached, (v) what is the amount of applications that had one or more children's names attached, (vi) what is the amount of applications that had a dependent other than a marital spouse or a child attached, (vii) what is the total amount of persons' names on all applications; (b) of the total amount of persons' names accepted through written hearings, (i) what is the number broken down by country of origin, (ii) what is the amount of people for each age, broken down by age from 0 to 100 years old, (iii) what is the amount of people broken down by gender, (iv) what is the amount of people showing English language proficiency, (v) what is the amount of people showing French language proficiency, (vi) what is the amount of people showing both English and French language proficiency?

Q-2762² — June 4, 2024 — — With regard to the statement on page 99 of the 2023 Fall Economic Statement that "The government will begin purchasing up to an annual maximum of $30 billion of Canada Mortgage Bonds, starting as early as February 2024": (a) when did the government begin purchasing the bonds; (b) what is the amount and value of the bonds purchased to date; (c) what are the government's projections in relation to how much of the $30 billion in bonds per year the government expects to default or write-off; and (d) what specific measures, if any, are in place to ensure that the government's finances are not adversely impacted by any increase in the default rate of these bonds?

Q-2763² — June 4, 2024 — — With regard to performance audits or similar types of assessments related to passport processing times, which were ongoing or have been conducted since May 1, 2022: what are the details of each audit or assessment, including, for each, the (i) start and end dates of the time period audited or assessed, (ii) summary and scope of the audit or assessment, (iii) findings, (iv) recommended changes to improve processing times, if applicable, (v) changes that were implemented, (vi) entity responsible for conducting the audit or assessment?

Q-2764² — June 4, 2024 — — With regard to government expenditures on gala, concert or sporting event tickets, since January 1, 2023: what was the (i) date, (ii) location, (iii) total cost, (iv) cost per ticket, (v) number of tickets, (vi) title of the persons using the tickets, (vii) name or title of the event for which tickets were purchased by, or billed to, any department, agency, Crown corporation, or other government entity?

Q-2765² — June 4, 2024 — — With regard to the Canadian Radio-television and Telecommunications Commission's (CRTC) decision, announced in June 2024, that it would require online streaming services to pay five percent of their Canadian revenues to CRTC as part of implementing the measures contained in Bill C-11, An Act to amend the Broadcasting Act and to make related and consequential amendments to other Acts: (a) how many different streaming services does the CRTC expect to receive payments from; (b) how much annual revenue does the CRTC expect to receive; (c) what assurances, if any, has the CRTC received to ensure that the 5% percent is not passed on to consumers in the form of higher subscription prices; and (d) what analysis, if any, was done on the impact of higher subscription prices as a result of the payment requirement on inflation or the cost of living?

Q-2766² — June 4, 2024 — — With regard to the revelation by the Parliamentary Budget Officer (PBO) at the Standing Committee on Finance on June 3, 2024, that "the government has economic analysis on the impact of the carbon tax itself and the OBPS. We've seen that, staff in my office, but we've been told explicitly not to disclose it": (a) who in the government issued this gag order on the PBO; (b) what were the findings of any economic analysis which was subject to the gag order; (c) why was the gag order issued; and (d) how does the gag order comply with the Prime Minister's commitment in 2015 to provide Canadians with the most transparent and open government in the world?

Q-2767² — June 5, 2024 — — With regard to projected government spending from now until 2030: (a) broken down by year, how much will be spent through the (i) 2 Billion Trees program, (ii) Nature Smart Climate Solutions Fund, (iii) Agricultural Climate Solutions program; and (b) what is the breakdown of (a)(iii) by program stream?

Q-2768² — June 5, 2024 — — With regard to the temporary foreign worker programs for caregivers, broken down by year since 2019 until 2024: (a) what is the total amount of workers hired through the (i) Home Child Care Provider Pilot (HCCPP), (ii) Home Support Worker Pilot (HSWP); (b) broken down by province and territory, what is the total amount of workers hired under the (i) HCCPP, (ii) HSWP; (c) what is the median annual household income of families that hired workers through the (i) HCCPP, (ii) HSWP; (d) what is the average annual household income of families that hired workers through the (i) HCCPP, (ii) HSWP; (e) what is the total amount of families that hired a worker through the HCCPP that had an annual household income of (i) less than $100,000, (ii) between $100,000 and $200,000, (iii) between $200,000 and $300,000, (iv) between $300,000 and $400,000, (v) between $400,000 and $500,000, (vi) between $500,000 and $600,000, (vii) over $600,000; (f) what is the total amount of families that hired a worker through the HSWP that had an annual household income of (i) less than $100,000, (ii) between $100,000 and $200,000, (iii) between $200,000 and $300,000, (iv) between $300,000 and $400,000, (v) between $400,000 and $500,000, (vi) between $500,000 and $600,000, (vii) over $600,000; (g) what is the total amount of workers, broken down by year, who went on to gain permanent resident status who were hired under the (i) HCCPP, (ii) HSWP; (h) broken down by country of origin, what is the total amount of workers brought in through the (i) HCCPP, (ii) HSWP; and (i) what is the total amount of reports of abusive working conditions under the (i) HCCPP, (ii) HSWP?

Q-2769² — June 5, 2024 — — With regard to the Benefits Delivery Modernization programme: (a) what are the projected scope, full technology requirements, and projected procurement needs presented in the latest $4.4 billion dollar budget for the programme in 2024, as announced by the Minister of Citizens' Services on May 6, 2024, at the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities; (b) what is the itemized breakdown of how the $4.4 billion is projected to be spent; (c) what are the details of travel expenses incurred by the government related to third-party contractors working on the programme since January 1, 2017, including the (i) dates, costs, and flight details of all flights expensed by third-party contractors, (ii) dates, costs, and locations of lodgings expensed by third-party contractors, (iii) dates, costs, and items charged as per diems expensed by third-party contractors; and (d) what is the breakdown of (c)(i) to (c)(iii) by (i) month, (ii) quarter, (iii) third-party contractor?

Q-2770² — June 5, 2024 — — With regard to cyberattacks on government servers since January 1, 2021, broken down by department or agency and by year: (a) how many attempted cyberattacks are estimated to have occurred; (b) how many cyberattacks resulted in the server or data being compromised in any way; (c) what is the breakdown of (b) by the resulting damage (data stolen, server mined, unknown, etc.); (d) for each instance where data was stolen or compromised, (i) what was the date, (ii) how many individuals' data was involved, (iii) how were the affected individuals notified, (iv) what is the incident summary; and (e) for each instance in (b) where an individual's data was not involved, (i) what was the date, (ii) what is the incident summary, (iii) what damage, if any, was caused to any government servers, networks, or equipment?

Q-2771² — June 5, 2024 — — With regard to applications received by the government to run supervised consumption sites, since 2015 and broken down by province or territory: (a) what are the addresses and services offered or potentially offered for each application received; and (b) for each application in (a), broken down by address or site, is the status of the application (i) received but a decision has not yet been made, (ii) approved but not yet operational, (iii) approved and operational, (iv) rejected?

Q-2772² — June 6, 2024 — — With regard to expenditures on coaching since January 1, 2017, broken down by year and by department or agency: (a) how many contracts were signed by the government for coaching; (b) what was the total value of the coaching contracts signed; (c) what are the details of each contract or similar type of agreement for coaching public servants, including, for each, the (i) date, (ii) vendor, (iii) type of coaching, (iv) purpose of the contract, (v) value, (vi) names and titles of the public servants receiving coaching; (d) what are the details of each contract or similar type of agreement for coaching ministers or exempt staff members, including, for each, the (i) date, (ii) vendor, (iii) type of coaching, (iv) purpose of the contract, (v) value, (vi) names and titles of the individuals who received the coaching; (e) what are the details of each contract or similar type of agreement for coaching any individuals not covered in (c) or (d), including, for each, the (i) date, (ii) vendor, (iii) type of coaching, (iv) purpose of the contract, (v) value, (vi) names and titles of those who received coaching; and (f) for each contract in (c) through (e), (i) what was the desired outcome, (ii) how was the outcome measured, if it was measured, (iii) what outcome was achieved?

Q-2773² — June 6, 2024 — — With regard to Disaster Mitigation Adaptation Fund applications received from communities in British Columbia since 2021: (a) what are the details of all applications which were denied funding, including, for each, the (i) name of the city, town or municipality, (ii) date of the application, (iii) disaster event related to the application, (iv) reason that the funding was denied; (b) what specific criteria is used, including any scoring or grading system, to determine whether an application is approved or denied; and (c) if a scoring or grading system was used, what score or grade was given to each application in (a)?

Q-2774² — June 7, 2024 — — With regard to meetings held between the US Ambassador, David Cohen, and the Minister of Innovation, Science and Industry or the Deputy Minister: what are the details of all meetings in which the Artificial Intelligence and Data Act has been raised, including, the (i) date and time, (ii) names and titles of those in attendance, (iii) location, (iv) summary of the discussions?

Q-2775² — June 7, 2024 — — With regard to the list of over 300 meetings held on Bill C-27, An Act to enact the Consumer Privacy Protection Act, the Personal Information and Data Protection Tribunal Act and the Artificial Intelligence and Data Act and to make consequential and related amendments to other Acts, submitted to the Standing Committee on Industry and Technology on November 21, 2023: what are the details of each meeting, broken down by the (i) date that it occurred, (ii) names of all persons that attended, (iii) topic of discussion related to the meeting, (iv) proposed sections of the bill on which the amendments were discussed?

Q-2776² — June 7, 2024 — — With regard to international trips taken by the Minister of Foreign Affairs since November 4, 2015: what are the details of all trips where the minister has introduced and discussed topics related to fisheries and fisheries management, including, for each, (i) the names and titles of those in attendance, (ii) the date and time of the meeting, (iii) the location of the meeting, (iv) a summary of the specific topic discussed at the meeting?

Q-2777² — June 7, 2024 — — With regard to individual expense receipts submitted by a board of director, chair, or CEO, at Export Development Canada, since 2018: what are the details of all items expensed, including the (i) dollar value of each expense, (ii) product or service expensed, (iii) name of the venue for the product or service expensed, (iv) name of the city in which it was expensed, (v) reason for the expense, (vi) name and title of the individual it was expensed under?

Q-2778² — June 7, 2024 — — With regard to the funding provided by Innovation, Science and Economic Development Canada (ISED) to the MaRS Discovery District (MaRS): what are the details of all agreements between ISED and MaRS since November 4, 2015, including, for each, the (i) value of any funding received, (ii) form of funding received, (iii) date that the agreement was agreed to by both parties, (iv) details on the purpose of the agreement, (v) intended use of the funding by MaRS in their role as a registered charity?

Q-2779² — June 7, 2024 — — With regard to the construction and planned construction of all ships under the Canadian Surface Combatant procurement project of the National Shipbuilding Procurement Strategy, since the program was introduced: (a) for each ship, what percentage of all materials and equipment was initially planned to be of Canadian manufacturing and origin, and what was the percentage at the time of completion; and (b) what is the specific origin and manufacturer of all materials and equipment used?

Q-2780² — June 7, 2024 — — With regard to the 2017 mandate of the Department of Fisheries and Oceans (DFO) to negotiate timelimited Rights Reconciliation Agreements with First Nations in Atlantic Canada and Quebec: what are the details of all agreements under this mandate, including, for each, (i) the name or title of the agreement, (ii) a detailed summary, (iii) the date that the agreement was signed, (iv) the names of the First Nations with whom DFO signed the agreement, (v) the names and titles of the individuals at DFO who signed the agreement?

Q-2781² — June 7, 2024 — — With regard to the Minister of Innovation, Science and Industry being listed on the Bilderberg Meetings website as a participant at the 2024 Bilderberg meeting in Madrid, Spain: (a) did the minister attend the meeting; (b) what was the minister's detailed itinerary while in Spain for the meetings; (c) what were the agenda items at the meeting; (d) did the minister meet with fellow participant Mark Carney while in Spain, and, if so, what did they discuss; (e) with whom did the minister have meetings with while at Bilderberg, and what was discussed at each meeting; and (f) were any costs incurred by the government related to the minister's attendance at the meeting, and, if so, what is the detailed breakdown of the costs?

Q-2782² — June 7, 2024 — — With regard to the April 7, 2021 decision of the former Minister of Justice, Hon. David Lametti, ordering a new trial for Jacques Delisle: (a) what are the details of all legal advice received by the former minister regarding the holding of a new trial, including, for each instance, (i) the identity of the person who provided the advice, (ii) the mandate conferred by the minister, (iii) the evidence reviewed; and (b) what are the details of the 2017 Criminal Conviction Review Group (CCRG) report on former justice Delisle’s case, including the (i) evidence reviewed, (ii) conclusion, (iii) recommendation made to the minister?

Q-2783² — June 10, 2024 — — With regard to the government’s purchase of GeneXpert Systems for rapid diagnostic testing acquired to facilitate access to rapid testing for SARS-CoV-2: (a) how many GeneXpert Systems are owned by Health Canada and, of those, how many are currently being operated; (b) what kinds of testing are the machines currently being used for; (c) is the government planning on using the full range of testing capabilities of the GeneXpert Systems to test for other infectious diseases such as HIV and Hepatitis C; and (d) is there a plan for the use of the GeneXpert systems to help counter increasing rates of new HIV and Hepatitis C cases, and, if so, (i) how will new locations be chosen and will community-based organizations be prioritized, (ii) will this plan include provisions for training operators to ensure proper use and accurate results, (iii) will this plan have provisions to ensure the financial sustainability to guarantee ongoing operations?

Q-2784² — June 10, 2024 — — With regard to the $5 billion in funding through the Disaster Financial Assistance Arrangements to British Columbia, committed in the 2021 Fall Economic Statement, in response to extreme weather events: (a) how much of this commitment has been delivered to British Columbia to date, in total, and broken down by specific project funded; (b) when will the outstanding amount be delivered; and (c) what is required before the outstanding amount is provided to British Columbia?

Q-2785² — June 10, 2024 — — With regard to government knowledge of 69 shipping containers sent from Canada to the Philippines during the years of 2013 and 2014 by the export company Chronic Inc. and subsequently returned to Canada after being held in port for five years: (a) when did the issue first come to the attention of (i) Global Affairs Canada, (ii) Environment and Climate Change Canada, (iii) the Office of the Prime Minister, and what was the government’s initial understanding of the situation; (b) was an audit, analysis, or other form of testing completed on the contents of these 69 shipping containers, and, if so, (i) who performed the audit, (ii) who requested that the audit be performed, (iii) what communications exist, if any, around the ordering and results of the audit, (iv) what were the results of the audit, specifically regarding the percentage of recyclable materials making up the contents of the shipping containers and the acceptability of the contents in relation to existing standards and thresholds, (v) was any of the waste considered hazardous, (vi) was the return of these shipping containers to Canada justified by the outcomes of the audits performed; (c) if the audit referred to in (b) demonstrated results within the acceptable threshold, why did the government decide to return the shipping containers to Canada; and (d) what action, including any legal remedies, is the government taking, or consideration taking, against Chronic Inc. and its owner?

Q-2786² — June 10, 2024 — — With regard to Innovation, Science, and Economic Development Canada’s wireless infrastructure, broken down by year since January 1, 2016: (a) how much money has been collected in revenues from (i) wireless spectrum auctions, (ii) annual wireless spectrum licensing fees; (b) what were the total amounts given as grants and contributions towards the construction, improvement or expansion of wireless infrastructure; and (c) what is the breakdown of (b) by wireless provider or company directly impacted by the grant or contribution?

Q-2787² — June 10, 2024 — — With regard to Transport Canada and airport authorities, broken down by year since January 1, 2016: (a) what is the total amount of taxes, fees, rent payments, and lease payments collected from airport authorities, broken down by airport; and (b) what are the total amounts given as grants and contributions to airport authorities for infrastructure improvements, broken down by (i) airport, (ii) project funded?

Q-2788² — June 10, 2024 — — With regard to complaints received by the Canadian Radio-television and Telecommunications Commission, broken down by year since January 1, 2016: (a) what is the total number of complaints (i) received, (ii) resolved; (b) what was the average resolution time, in days, for complaints regarding (i) radio, (ii) television, (iii) telecommunications, (iv) other, broken down by type; (c) what is the total number of complaint proceedings (i) started, (ii) completed; and (d) what is the average completion time, in days, for proceedings in (i) radio, (ii) television), (iii) telecommunications, (iv) other?

Q-2789² — June 10, 2024 — — With regard to complaints received by the Financial Consumer Agency of Canada, broken down by year since January 1, 2016: (a) what is the total number of complaints (i) received, (ii) resolved; and (b) for all the complaints in (a), what are the types of bodies the complaints are between, broken down by (i) person to person, (ii) business to person, (iii) person to business, (iv) business to business?

Q-2790² — June 10, 2024 — — With regard to surveys commissioned by the Privy Council Office since January 1, 2019: (a) were there any surveys commissioned aiming to obtain polling or opinion data on (i) proposed government policies or legislation, (ii) government policies or legislation already in place, (iii) the performance of government departments or agencies themselves, (iv) the performance of the government itself, (v) the Canada Carbon Rebate, (vi) the Safer Supply Program, (vii) the exemption granted to British Columbia under the Controlled Drugs and Substances Act to decriminalize certain substances; and (b) for each survey in (a), (i) what was the purpose, (ii) what were all questions asked, (iii) what were the answers received, (iv) what costs were associated with the survey, in total and broken down by type of expense, (v) what external suppliers and consultants were used to commission the survey, (vi) what external suppliers and consultants were used to analyze and collect the results of the survey, (vii) how many responses were received, (viii) who did the survey target, (ix) was the survey available to all Canadians, and, if not, who was able to respond to the survey, (x) what year was the survey commissioned in, (xi) what department or agency issued the survey?

Q-2791² — June 10, 2024 — — With regard to the Next Generation Human Resources and Pay system's development, procurement and test trials: (a) how much has been spent to date on the system; (b) which companies bid on the project; (c) how many points were attributed to the bid of each company in (b); (d) which company or companies were chosen to test their systems in government departments; and (e) for each company that was chosen to test their systems, which departments, agencies, or other government entities, did each of these companies test their systems in?

Q-2792² — June 10, 2024 — — With regard to Canada Post's climate action targets: (a) how much has Canada Post spent on carbon offsets each year since 2015; and (b) how much has Canada Post spent to date on solar panels (i) in total, (ii) broken down by province or territory, (iii) broken down by location or post office?

Q-2793² — June 10, 2024 — — With regard to Parks Canada, for each fiscal year between 2010 and 2024: (a) in which national parks did the agency operate life guard and surf guard programs; (b) how much funding did each park receive to administer these programs; (c) how many staff worked in each park in support of these programs; (d) how many visitors accessed each park, broken down by year; and (e) how many rescues or contacts were made under these programs, broken down by park?

Q-2794² — June 11, 2024 — — With regard to the Canada Pension Plan Investment Board (CPPIB), broken down by year since January 1, 2019: (a) how many cases of (i) gender discrimination, (ii) disability discrimination, were filed against the CPPIB; (b) of the cases in (a), how many were settled without formal litigation; (c) how many nondisclosure agreements were signed by former employees related to the cases in (a); (d) what percentage of the employee disciplinary actions and terminations were handled (i) internally by employee relations, (ii) by external counsel; (e) what is the breakdown of the number of discrimination cases filed against the CPPIB in each of its offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (f) which law firms were hired to represent the CPPIB and, broken down by city, what was the total amount in legal fees paid to each firm; (g) how much was paid in legal fees for (i) employee terminations, (ii) employee-initiated legal action against the CPPIB for which the CPPIB retained legal counsel; (h) what was the total severance paid out in each of its offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (i) which laws firms were hired and retained by the CPPIB in the offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (j) what were the legal fees paid annually for each of the law firms retained by the CPPIB to defend the CPPIB; (k) how many female employees were terminated through restructuring from Senior Associate level to Managing Director level for each of its offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (I) how many female employees were terminated through voluntary resignations from Senior Associate level to Managing Director level for each of its offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (m) how many (i) female, (ii) male, employees were promoted above the Senior Associate level; (n) what is the percentage of female departures from the Executive and Senior management pool from the CPPIB in its entirety and for each of its offices located in (i) Brazil, (ii) Hong Kong, (iii) India, (iv) London, (v) New York, (vi) San Francisco, (vii) Toronto; (o) what is the number of disability accommodation cases for (i) long-term, (ii) short-term, (iii) permanent, disability that were sent through Manulife; (p) how many employees who went through a Manulife accommodation remain with the CPPIB; (q) how many of the employees who remain with the CPPIB have been promoted in the last five years; (r) how many formal complaints brought by employees went through (i) a CPPIB Clearview Connects Whistleblower process, (ii) a CPPIB Conduct Review Advisor, (iii) a Legal and Compliance CPPIB, (iv) human resources; and (s) broken down by each part of (r), how many of the complainant employees remain employed by the CPPIB?

Q-2795² — June 11, 2024 — — With regard to Elections Canada (EC) and Communications Security Establishment Canada's reports on "Cyber threats to Canada's democratic process - 2023 update" and "Cyber security guidance for elections authorities (ITSM.10.020)": (a) what measures has EC taken since the last general election to safeguard the integrity of elections, candidates and campaigns against cyber threats, including (i) deepfakes, (ii) artificial intelligence, (iii) bots, (iv) other attacks on telecommunication infrastructure (such as "distributed denial of service" attacks) that aim to disrupt, interfere with or sway elections as warned against in the reports; (b) for each measure in (a), (i) what was the cost, (ii) when was it implemented, (iii) how and from whom was the measure originally proposed; and (c) are there any threats which EC does not have the capacity to fully guard against, and, if so, what are they, and has EC sought assistance from the government or any other entity to guard against such a threat, and, if so, what are the details?

Q-2796² — June 11, 2024 — — With regard to federal funding to non-governmental organizations that advocate pro-life or anti-abortion views, broken down by department and agency and by fiscal year since January 1, 2006: (a) what organizations received federal funding; and (b) how much federal funding was received?

Q-2797² — June 11, 2024 — — With regard to federal investments in Canada’s oil and gas sector, since January 1, 2006: how much federal funding has been provided to (i) Cenovus Energy Inc., (ii) Suncor Energy Inc., (iii) Imperial Oil Ltd., (iv) Enbridge Inc., (v) Canadian Natural Resources Ltd., broken down by company, year, and type of funding?

Q-2798² — June 11, 2024 — — With regard to federal court cases, since January 1, 2006: how many court cases have been initiated by the federal government against Indigenous organizations and governments, broken down by year and by affiliation (i) Inuit, (ii) Métis, (iii) First Nation?

Q-2799² — June 11, 2024 — — With regard to the government’s response to the COVID-19 pandemic and its reliance on the National Advisory Committee on Immunization (NACI) for their “independent, expert advice” (source: Order Paper question Q-2554): (a) in 2020 and 2021, what specific studies demonstrated that the COVID-19 vaccines would prevent (i) all, (ii) any, transmission of SARS-CoV-2; (b) what specific studies demonstrated that the COVID-19 vaccines were ineffective or would not completely prevent transmission of SARS-CoV-2; (c) in 2020 and 2021, what specific data was provided by the manufacturers of the approved COVID-19 vaccines in Canada that demonstrated that the COVID-19 vaccines were effective in preventing transmission of SARS-CoV-2; (d) with respect to informed consent in 2021, how was the uncertainty or “unknown” evidence around “the effectiveness against virus transmission, and long-term effectiveness against infection and severe disease” communicated to the Canadian public and medical professionals administering the vaccines; (e) without certainty that the vaccine would prevent transmission, what was the rationale provided to the Office of the Prime Minister from the Public Health Agency of Canada, Health Canada or NACI in support of the following measures in relation to only unvaccinated healthy individuals presenting with no symptoms (i) PCR testing before entering the country, (ii) quarantining individuals before entering the country, (iii) showing one’s vaccine status through a vaccine passport, (iv) preventing their travelling on federally-regulated transportation; (f) who advised the Office of the Prime Minister about the uncertainty of the COVID-19 vaccines with respect to its inability to prevent transmission of SARS-CoV2 and when; (g) what was the source of the messaging used by (i) the Chief Public Health Officer, (ii) the Deputy Chief Public Health officer, (iii) the Chief Medical Officer of Health Canada, (iv) the Minister of Health, (v) the Prime Minister, (vi) other government or public health officials, to state that COVID-19 vaccination would protect others, implying it stopped viral transmission; and (h) who approved the messaging in (g)?

Q-2800² — June 11, 2024 — — With regard to Transport Canada and meetings concerning Unidentified Aerial Phenomena (UAP): (a) when Patrick Juneau was the Director of Aviation Safety Policy and Intelligence at Transport Canada, did he meet with any United States officials on the subject of UAP, and, if so, what are the details of all such meetings, including, for each, (i) the date, (ii) the location, (iii) the names and titles of those in attendance, (iv) what was discussed or agreed upon; (b) have any Transport Canada officials other than Patrick Juneau met with any United States officials on the subject of UAP, and, if so, who and what are the details of all such meetings attended by any Transport Canada official, including, for each, (i) the date, (ii) the location, (iii) the names and titles of those in attendance, (iv) what was discussed or agreed upon; and (c) what are the details, including the website where the agreement can be read, of any UAP information sharing agreements that Transport Canada is aware of, between Canadian entities and American entities?

Q-2801² — June 11, 2024 — — With regard to government funding of non-governmental organizations or groups, from November 4, 2015, to the present: (a) how much money has the government allocated to Dunsky Energy + Climate Advisors and what are the details, including, the (i) department, agency or other government entity, (ii) date of the funding, (iii) amount and deliverables expected; (b) of the allocations in (a), which ones were (i) sole-sourced, (ii) awarded through a competitive bidding process; (c) of the allocations in (b)(ii), what was the (i) duration of the competition, (ii) number of organizations that submitted bids for the required deliverables; and (d) what programs from the organization in (a) received government funding, broken down by year and deliverables expected?

Q-2802² — June 11, 2024 — — With regard to funding provided through the Disaster Mitigation and Adaptation Fund, since January 1, 2021: (a) what is the amount provided through the fund to date, in total and broken down by province or territory; and (b) what are the details of all funding recipients, including, for each, the (i) date of the funding, (ii) amount, (iii) recipient, (iv) location, (v) description of the related disaster event, (vi) purpose of the funding?

Q-2803² — June 11, 2024 — — With regard to requests received by Health Canada related to decriminalization from provinces, municipalities or Indigenous communities, since January 1, 2016: what are the details of all such requests, including, for each, the (i) date, (ii) name and title of the person who made the request, (iii) entity represented by the person making the request, (iv) summary of the request, (v) response by Health Canada?

Q-2804² — June 11, 2024 — — With regard to Global Affairs Canada's Canada Fund for Local Initiatives (CFLI), broken down by year since January 1, 2016: (a) how much funding was provided through the CFLI, in total and broken down by country; and (b) how many projects were funded in each country?

Q-2805² — June 11, 2024 — — With regard to the Department of National Defence's decision to move employees working out of offices at 400 Cumberland Street to the Major-General George R. Pearkes Building due to safety concerns: (a) how much is the move expected to cost, in total and broken down by type of expense; (b) how many employees are being moved; (c) did the department make any representations to the Minister of Justice that the government's catch and release justice policies were creating safety concerns for their employees, and, if so, what are the details; and (d) if the department did not make any such representations to the Minister of Justice, why were they not made?

Q-2806² — June 11, 2024 — — With regard to the information provided in the government's response to Order Paper question Q-2542 as it relates to the project budget of the Canada Digital Adoption Program: (a) what is the itemized breakdown of all expenditures included under the Indirect Costs category; (b) what is the itemized breakdown of all equipment expenses included under the Direct Equipment category; (c) what is the itemized breakdown of all expenditures included under the Subcontracting costs category; (d) what is the itemized breakdown of expenditures included under the Other Direct Costs category; and (e) what is the breakdown of (a) through (d) by month and fiscal year?

Q-2807² — June 11, 2024 — — With regard to federal funding to non-governmental organizations, broken down by department and agency and fiscal year since January 1, 2006: (a) has (i) Campaign Life Coalition, (ii) LifeCanada, (iii) Alliance for Life Ontario, (iv) Alberta Pro-Choice Coalition, (v) Abortion Rights Coalition of Canada, (vi) Action Canada for Sexual Health and Rights, (vii) National Abortion Federation, (viii) Ontario Coalition for Abortion Clinics, received federal funding; and (b) how much federal funding, if any, was received by each organization listed in (a)?

Q-2808² — June 11, 2024 — — With regard to Health Canada’s (HC) approval of the modRNA COVID-19 vaccines manufactured by Pfizer and Moderna and distributed throughout Canada, its mechanism of action and the elements of which they are comprised: (a) how many copies of the modRNA molecule are in a single dose, for both the Pfizer and Moderna products, (i) for adults, (ii) for children; (b) how many copies of the antigen are in a single adult dose of Novavax; (c) if there is a significant numerical difference between the answers for (a) and (b), does this affect the immunological response; (d) how many copies of dsDNA are found in a single 30 microliter adult dose of (i) Pfizer’s product, (ii) Moderna’s product; (e) was a request made to Pfizer-BioNTech and Moderna regarding the DNA size distribution in the vaccine and, if so, (i) what proportion of the total DNA quantity were under 200bp, (ii) what was the average, range and standard deviation; (f) what is the function of the modRNA; (g) what is the function of the lipid nanoparticles (LNPs); (h) what is the specific role(s) of N1-methyl-pseudouridine as used in the modRNA of the vaccines; (i) what safety data was available to HC at the time of approval and is currently available, regarding any and repeat exposure to the following in human cells (i.e., safety, efficacy, toxicity): (i) large amounts of N1-methyl-pseudouridine, (ii) dsRNA, (iii) cytosolic DNA, (iv) lipid nanoparticles; (j) with regard to the research underpinning (g), has a risk assessment been performed of the LNPs separately from that of the drug product for safety, toxicity; (k) does HC have any degradation data for the modRNA in the vaccines and, if so, what does the data show; (l) what is the duration of action of modRNA from the COVID-19 mRNA in the body and how was that measured; (m) in what cells and organs is spike protein most likely to be produced in the body; (n) in which cell types and tissues does the modRNA remain for the longest period of time and second longest period of time, and what are the time periods; (o) for what period of time does a person injected with modRNA produce spike protein; (p) is the production of spike protein dependent on cell type; (q) is there a known correlation between the amount of modRNA in the vaccine and the amount of spike protein produced by the cells; (r) has HC performed a risk assessment on the immunological, toxicological and carcinogenicity of the spike protein and, if so, what was the analysis, and, if not, why weren't these risk assessments considered necessary; (s) if production of spike protein antigen is prolonged for greater than three to five days, does prolonged exposure lead to ongoing production of antibodies; (t) if the answer to (s) is negative, will a study or investigation be undertaken to determine this; (u) if the answer to (s) is affirmative, and if antibodies are the indicator of immunity, why does efficacy wane with time when the antigen production is prolonged; (v) has the purity of the modRNA contained in the COVID-19 vaccines been determined; (w) if the answer to (v) is affirmative, what is the present accepted limit of fragmented and truncated modRNA; (x) if the answer to (v) is negative, why hasn’t the purity of the modRNA been established; (y) if production of spike protein expression is prolonged for more than three to five days, are there harmful sequelae to prolonged exposure; and (z) if the answer to (y) is affirmative, what are those harmful sequelae?

Q-2809² — June 11, 2024 — — With regard to Health Canada’s (HC) assessment of risks versus benefits for the COVID-19 vaccines: (a) did HC perform a formal analysis showing that the benefits of the COVID-19 vaccines outweigh the risks (i) at the time of interim order approval, (ii) at the time of authorization, under the amended Food and Drugs Regulation for September 2021, (iii) before the approval of each subsequent booster; (b) if the answer to (a) is affirmative, who performed the analysis and what were the results of the analysis, specifying the benefits and risks (i) at the time of interim order approval, (ii) at the time of authorization, under the amended Food and Drugs Regulation for September 2021, (iii) before the approval of each subsequent booster; (c) what specific scientific studies, real world data, and Canadian morbidity and mortality data were reviewed by HC to conclude the risks of the COVID-19 vaccines outweighed the risk of COVID-19 illness (i) at the time of interim order approval, (ii) at the time of authorization, under the amended Food and Drugs Regulation for September 2021, (iii) before the approval of each subsequent booster; (d) what were the risks that HC determined for the COVID-19 vaccines compared to the risks of the COVID-19 illness (i) stratified across age groups, (ii) for the immunocompromised, (iii) for seniors with two or more comorbidities, (iv) for pregnant and lactating women, and what were these results; (e) did HC use the Cleveland study entitled “Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine” by N. Shrestha et al to update their risk-benefit analysis of the current COVID-19 vaccine; (f) if the answer to (e) is negative, why not; (g) how were those individuals who received a COVID-19 vaccine classified as being “vaccinated” versus “unvaccinated” for the purposes of statistical analysis of clinical outcomes and vaccine efficacy by the following categories (i) less than two weeks after first dose of the primary series, (ii) between two weeks and three months after first dose of the primary series, (iii) less than two weeks after second dose of the primary series, (iv) more than two weeks after second dose of the primary series, (v) less than two weeks after any booster dose, (vi) more than six months after any booster dose; (h) would the response in (g) be influenced by brand of COVID-19 vaccine, and, if so, how; (i) for Canadian morbidity and mortality data presented to the Canadian public to illustrate the efficacy of the COVID-19 vaccines, how were the definitions from (g) and (h) used; and (j) what data supported the definitions of the vaccination status as defined in (g)?


¹ Requires Oral Answer ² Response requested within 45 days